[go: up one dir, main page]

WO2007031168A1 - Perles de culture pulverisees dans des agents cosmetiques - Google Patents

Perles de culture pulverisees dans des agents cosmetiques Download PDF

Info

Publication number
WO2007031168A1
WO2007031168A1 PCT/EP2006/008109 EP2006008109W WO2007031168A1 WO 2007031168 A1 WO2007031168 A1 WO 2007031168A1 EP 2006008109 W EP2006008109 W EP 2006008109W WO 2007031168 A1 WO2007031168 A1 WO 2007031168A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
preferred
oil
hair
derivatives
Prior art date
Application number
PCT/EP2006/008109
Other languages
German (de)
English (en)
Inventor
Petra Somfleth
Erik Schulze Zur Wiesche
Original Assignee
Henkel Kommanditgesellschaft Auf Aktien
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kommanditgesellschaft Auf Aktien filed Critical Henkel Kommanditgesellschaft Auf Aktien
Priority to EP06776913A priority Critical patent/EP1924241A1/fr
Publication of WO2007031168A1 publication Critical patent/WO2007031168A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9741—Pteridophyta [ferns]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/12—Preparations containing hair conditioners

Definitions

  • the invention relates to cosmetic compositions containing a synergistically effective combination of a pearl powder and at least one short-chain carboxylic acid, its derivatives and / or vitamin precursors, or plant extracts or proteins and / or protein hydrolysates and their use for the treatment of skin and hair, in particular for cleaning and / or care of skin and hair.
  • human hair is today treated in a variety of ways with hair cosmetic preparations. These include, for example, the cleansing of hair with shampoos, the care and regeneration with rinses and cures and the bleaching, dyeing and shaping of the hair with dyes, tinting agents, waving agents and styling preparations. In this case, means for changing or nuancing the color of the head hair play a prominent role.
  • the bleaching agents that cause an oxidative lightening of the hair by degradation of the natural hair dyes, so in the field of hair coloring essentially three types of hair dye are of importance:
  • oxidation colorants For permanent, intensive colorations with corresponding fastness properties, so-called oxidation colorants are used. Such colorants usually contain oxidation dye precursors, so-called developer components and coupler components. The developer components form under the influence of oxidizing agents or of atmospheric oxygen with one another or under coupling with one or more Coupler components from the actual dyes.
  • the oxidation stains are characterized by excellent, long lasting staining results.
  • dyeing or tinting agents which contain so-called direct drawers as a coloring component. These are dye molecules that grow directly on the hair and do not require an oxidative process to form the color. These dyes include, for example, the henna already known from antiquity for coloring body and hair. These dyeings are generally much more sensitive to shampooing than the oxidative dyeings, so that a much more undesirable nuance shift or even a visible "discoloration" occurs much more quickly.
  • the hair is treated with special active ingredients, for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • special active ingredients for example quaternary ammonium salts or special polymers, usually in the form of a rinse.
  • this treatment improves the combability, the hold and the fullness of the hair and reduces the splitting rate.
  • These preparations contain, in addition to the usual components, for example for the cleaning of the hair, in addition to active ingredients which were formerly reserved for the hair aftertreatment agents.
  • the consumer thus saves an application step; At the same time, packaging costs are reduced because one product is less needed.
  • active ingredients both for separate aftertreatment agents and for combination preparations generally have a preferential effect on the hair surface.
  • active ingredients are known which give the hair shine, hold, fullness, better wet or dry combabilities or prevent splitting.
  • the internal structural cohesion of the hair fibers which can be greatly influenced, in particular, by oxidative and reductive processes such as dyeing and perming.
  • Structural strengthening that is to say restructuring in the context of the invention, is to be understood as meaning a reduction in the damage of keratinic fibers which has arisen due to the most diverse influences.
  • the restoration of natural strength plays an essential role.
  • Restructured fibers are distinguished, for example, by an improved gloss or by an improved grip or by easier combing.
  • they have an optimized strength and elasticity.
  • a successful restructuring can be physically detected as a melting point increase compared to the damaged fiber. The higher the melting point of the hair, the firmer the structure of the fiber.
  • a detailed description of the method for determining the melting range of hair can be found in DE 196 173 95 A1.
  • the German utility model DE 203 13 122 Ul describes the use of a pearl powder in cosmetic products for beautification and care of the skin.
  • Pearl powders are also referred to in the literature as mother-of-pearl powder.
  • nacreous powder as a pigment and / or filler in sunscreens, lipsticks, skin creams or make-up products is known.
  • mother-of-pearl powder as an abrasive in toothpastes is known.
  • keratinic fibers are significantly improved in their combability, in the grip, in the gloss and in their internal structure.
  • the moisture balance of the keratinic fibers is clearly positively influenced.
  • the fibers can absorb and store more moisture, which contributes to strengthening their internal structural cohesion.
  • the skin moisture is also positively influenced on the skin. But also the tissue is significantly strengthened and strengthened, which manifests itself for example in reduced wrinkling and a smoother and at the same time more elastic skin.
  • a first subject of the present invention are therefore cosmetic preparations containing an active substance complex A consisting of a pearl powder and a short-chain carboxylic acid and / or its derivative and at least one further compound selected from i) at least one vitamin and / or at least one vitamin precursor and / or a derivative the vitamins and / or vitamin precursors (K), ii) at least one plant extract (L), iii) at least one further protein and / or at least one further protein hydrolyzate (P) and iv) at least one silicone compound (S).
  • an active substance complex A consisting of a pearl powder and a short-chain carboxylic acid and / or its derivative and at least one further compound selected from i) at least one vitamin and / or at least one vitamin precursor and / or a derivative the vitamins and / or vitamin precursors (K), ii) at least one plant extract (L), iii) at least one further protein and / or at least one further protein hydrolyzate (P) and iv) at least
  • keratinic fibers are understood to mean furs, wool, feathers and, in particular, human hair.
  • Beads of mussels consist essentially of inorganic and organic calcium salts, trace elements and proteins. Pearls can be easily obtained from cultivated mussels. The cultivation of the mussels can be done in fresh water as well as in sea water. This can affect the ingredients of the beads.
  • Preferred according to the invention is a pearl powder which is obtained from freshwater pearls, in particular from the mussel Hyriopsis Schlegeli. Pearls generally consist largely of aragonite (calcium carbonate), conchiolin and an albumin. The latter components are proteins.
  • the amino acids found in the bead protein are aspartic acid, threonine, serine, glutamic acid, proline, glycine, cysteine, alanine, valine, methionine, isoleucine, leucine, tyrosine, phenylalanine, lysine, histidine, arginine and ornithine.
  • the amino acids are listed in order of their proportions, with the amino acids with the highest proportion being named first.
  • Also included in beads are magnesium and sodium salts, inorganic silicon compounds, and phosphates.
  • the beads are pulverized by conventional methods.
  • this pearl powder thus obtained is used. It is available, for example under the name Pearlpurin ® PP commercially.
  • the pearl powder is processed in a further process step.
  • the bead powder is subjected to a protein hydrolysis step as feedstock. This hydrolysis can be carried out by any known method. Following the hydrolysis, a drying process follows.
  • the present bead powder in which the protein components are partially or fully hydrolyzed is the second preferred embodiment of the bead powder.
  • Such pearl powder is available, for example under the trade name Pearlpurin ® PH.
  • a most preferred pearl powder contains at least 75%, preferably 85%, more preferably 90% and most preferably 95% of all ingredients of the naturally occurring beads.
  • the invention also includes that a synthetic powder containing all the ingredients of the pearl powder of the invention, such as the natural pearl powder can be used. However, this is not preferred according to the invention.
  • At least one of the above-described pearl powders is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the bead powder of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • one of the above-described pearl powders is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the extract of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • a first class of substances which is necessarily included in the synergistic active ingredient combination (A) according to the invention are vitamins, provitamins and vitamin precursors as well as their derivatives (K).
  • vitamins, provitamins and vitamin precursors are preferred, which are usually assigned to groups A, B, C, E, F and H.
  • vitamin A includes retinol (vitamin Ai) and 3,4-didehydroretinol (vitamin A 2 ).
  • the ß-carotene is the provitamin of retinol.
  • vitamin A component according to the invention for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration.
  • the preparations used according to the invention tions contain the vitamin A component preferably in amounts of 0.05-1 wt .-%, based on the total preparation.
  • the vitamin B group or the vitamin B complex include u. a.
  • Vitamin Bi thiamine
  • Vitamin B 2 riboflavin
  • Vitamin B 3 the compounds nicotinic acid and nicotinamide (niacinamide) are often performed.
  • Preferred according to the invention is the nicotinic acid amide which is contained in the agents used according to the invention preferably in amounts of from 0.05 to 1% by weight, based on the total agent.
  • panthenol pantothenic acid, panthenol and pantolactone.
  • Panthenol and / or pantolactone are preferably used in the context of this group.
  • Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are, for example, the panthenol triacetate, the panthenol monoethyl ether and its monoacetate and also the cationic panthenol derivatives disclosed in WO 92/13829.
  • the said compounds of the vitamin B 5 type are preferably contained in the agents used according to the invention in amounts of 0.05-10% by weight, based on the total agent. Amounts of 0.1-5 wt .-% are particularly preferred.
  • Vitamin B 6 pyridoxine and pyridoxamine and pyridoxal
  • Vitamin C (ascorbic acid). Vitamin C is used in the compositions according to the invention preferably in amounts of 0.1 to 3 wt .-%, based on the total agent. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.
  • Vitamin E tocopherols, especially ⁇ -tocopherol.
  • Tocopherol and its derivatives, including in particular the esters such as acetate, nicotinate, the phosphate and the Succinate are included in the compositions according to the invention preferably in amounts of 0.05-1 wt .-%, based on the total agent.
  • Vitamin F is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.
  • Vitamin H is the compound (3aS, 4S, 6a) -2-oxohexahydrothienol [3,4-c (] - imidazole-4-valeric acid, for which, in the meantime, the trivial name biotin has become established is contained in the compositions according to the invention preferably in amounts of 0.0001 to 1.0 wt .-%, in particular in amounts of 0.001 to 0.01 wt .-%.
  • the agents used according to the invention preferably contain vitamins, provitamins and vitamin precursors from groups A, B, E and H.
  • Panthenol, pantolactone, pyridoxine and its derivatives as well as nicotinic acid amide and biotin are particularly preferred.
  • a second class of substances which, as an alternative to the vitamins and / or vitamin precursors (K), is necessarily contained in the synergistic combination of active substances (A) according to the invention, are plant extracts (L).
  • extracts are produced by extraction of the whole plant. However, in individual cases it may also be preferred to prepare the extracts exclusively from flowers and / or leaves of the plant.
  • According to the invention are especially the extracts of green tea, oak bark, nettle, witch hazel, hops, henna, chamomile, burdock root, horsetail, linden blossom, almond, aloe vera, pine needle, horse chestnut, sandalwood, juniper, coconut, mango, apricot, lime , Wheat, kiwi, melon, orange, grapefruit, sage, rosemary, birch, mallow, meadowfoam, quenelle, yarrow, thyme, lemon balm, toadstool, coltsfoot, marshmallow, meristem, ginseng and ginger root.
  • Especially suitable for the use according to the invention are the extracts of green tea, almond, aloe vera, coconut, mango, apricot, lime, wheat, kiwi and melon.
  • alcohols and mixtures thereof can be used as extraction agent for the preparation of said plant extracts water.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as ethylene glycol and propylene glycol, both as sole extractant and in admixture with water, are preferred.
  • Plant extracts based on water / propylene glycol in a ratio of 1:10 to 10: 1 have proven to be particularly suitable.
  • the plant extracts can be used according to the invention both in pure and in diluted form. If they are used in diluted form, they usually contain about 2 to 80 wt .-% of active substance and as a solvent used in their extraction agent or extractant mixture. Furthermore, it may be preferred to use in the compositions according to the invention mixtures of several, especially two, different plant extracts.
  • Protein hydrolysates are product mixtures obtained by acid, alkaline or enzymatically catalyzed degradation of proteins (proteins).
  • the term protein hydrolyzates also means total hydrolyzates as well as individual amino acids and their derivatives as well as mixtures of different amino acids.
  • polymers made up of amino acids and amino acid derivatives are understood by the term protein hydrolyzates. The latter include, for example, polyalanine, polyasparagine, polyserine, etc.
  • Further examples of compounds which can be used according to the invention are L-alanyl-L-proline, polyglycine, glycyl-L-glutamine or D / L-methionine-S-methylsulfonium chloride.
  • ⁇ -amino acids and their derivatives such as ⁇ -alanine, anthranilic acid or hippuric acid can also be used.
  • the molecular weight of the protein hydrolysates which can be used according to the invention is between 75, the molecular weight for glycine, and 200,000, preferably the molecular weight is 75 to 50,000 and very particularly preferably 75 to 20,000 daltons.
  • protein hydrolysates of both vegetable and animal or marine or synthetic origin can be used.
  • Animal protein hydrolysates are, for example, elastin, collagen, keratin and milk protein protein hydrolysates, which may also be present in the form of salts.
  • Such products are, for example, under the trademarks Dehylan ® (Cognis), Promois® ® (Interorgana) Collapuron ® (Cognis), Nutrilan® ® (Cognis), Gelita-Sol ® (German Gelatinefabriken Stoess & Co), Lexein ® (Inolex) and kerasol tm ® (Croda) sold.
  • Preferred according to the invention is the use of protein hydrolysates of plant origin, eg. Soybean, almond, pea, potato and wheat protein hydrolysates.
  • Such products are, for example, under the trademarks Gluadin ® (Cognis), diamine ® (Diamalt) ® (Inolex), Hydrosoy ® (Croda), hydro Lupine ® (Croda), hydro Sesame ® (Croda), Hydro tritium ® (Croda) and Crotein ® (Croda) available.
  • protein hydrolysates Although the use of the protein hydrolysates is preferred as such, amino acid mixtures otherwise obtained may be used in their place, if appropriate. Also possible is the use of derivatives of protein hydrolysates, for example in the form of their fatty acid condensation products. Such products are sold for example under the names Lamepon® ® (Cognis), Lexein ® (Inolex), Crolastin ® (Croda) or crotein ® (Croda).
  • the protein hydrolysates (P) are present in the compositions in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.05% by weight to 15% by weight and most preferably in amounts of 0.05% by weight % up to 5% by weight.
  • An inventively preferred protein (P) in the active ingredient complex A is silk protein.
  • silk protein includes the following proteins and protein derivatives:
  • sericin hydrolyzed and / or further derivatized sericin, such as commercial products with the INCI names Sericin, Hydrolyzed Sericin, or Hydrolyzed SiIk
  • fibroin hydrolyzed and / or further derivatized fibroin, particularly partially hydrolyzed fibroin, which contains as its main constituent the amino acid sequence Ser-Gly-Ala-Gly-Ala-Gly, the amino acid sequence Ser-Gly-Ala-Gly-Ala-Gly,
  • one of the two silk proteins, fibroin and / or sericin is used in the native or at most solubilized form. According to the invention it is also possible to use a mixture of several silk proteins.
  • the derivatives of sericin and fibroin hydrolysates include both anionic and cationized protein hydrolysates.
  • the protein hydrolysates of sericin and fibroin according to the invention and the derivatives prepared therefrom can be prepared from the corresponding proteins by a chemical, in particular alkaline or acidic Hydrolysis, be obtained by enzymatic hydrolysis and / or a combination of both types of hydrolysis.
  • the hydrolysis of proteins usually results in a protein hydrolyzate having a molecular weight distribution of about 100 daltons up to several thousand daltons.
  • cationic protein hydrolysates of sericin and fibroin and / or derivatives thereof whose underlying protein content has a molecular weight of 100 to 25,000 daltons, preferably 250 to 10,000 daltons.
  • cationic protein hydrolysates of sericin and fibroin also mean quaternized amino acids and mixtures thereof.
  • the quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolysates may also be further derivatized.
  • cationic protein hydrolysates and derivatives those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 U Street, NW, Suite 300 Cocodimonium hydroxypropyl hydrolyzed silica, cocodimonium hydroxypropyl silicon, aminoacids, hydroxypropyltrimium hydrolyzed silica, lauryldimonium hydroxypropyl hydrolyzed silica, steardimonium hydroxypropyl hydrolyzed silica, quaternium-79 hydrolyzed silica, cocodimonium hydroxypropyl hydrolyzed silica, cited by Washington, DC 20036-4702).
  • anionic protein hydrolysates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 * Street, NW, Suite 300 Potassium cocoyl hydrolyzed silica, sodium lauroyl hydrolyzed silica or sodium stearoyl hydrolyzed silica.
  • the derivatives of sericin and fibroin which can be used according to the invention, mention may be made of the products commercially available under the INCI names: Ethyl Ester of Hydrolyzed SiIk and Hydrolyzed SiIk PG-Propyl Methylsilanediol.
  • Palmitoyl Oligopeptides Palmitoyl Pentapeptide-3, Palmitoyl Pentapeptide-2, Acetyl Hexapeptide-1, Acetyl Hexapeptide-3, Copper Tripeptide-1, Hexapeptide-1, Hexapeptide-2, MEA-Hydrolyzed SiIk.
  • compositions used according to the invention contain a silk protein and / or its derivative in amounts of 0.001-10% by weight, based on the total composition. Quantities of 0.005 to 5, in particular 0.01 to 3 wt .-%, are very particularly preferred.
  • a bead protein hydrolyzate or pearl extract is also preferred according to the invention.
  • the beads are pulverized. Thereafter, the pulverized beads are extracted by the usual methods.
  • extraction agent for the preparation of the pearl extracts water, alcohols and mixtures thereof can be used. Underwater are understood to mean both demineralized water and seawater.
  • the alcohols are lower alcohols such as ethanol and isopropanol, but especially polyhydric alcohols such as glycerol, diglycerol, triglycerol, polyglycerol, ethylene glycol, propylene glycol and butylene glycol, both as sole extractant and in admixture with demineralized water or sea water, preferably.
  • Polyhydric alcohols such as glycerol, diglycerol, triglycerol, polyglycerol, ethylene glycol, propylene glycol and butylene glycol, both as sole extractant and in admixture with demineralized water or sea water, preferably.
  • Pearl extracts based on water / glycerine mixtures have proven to be particularly suitable.
  • the pearl proteins can be largely in the native state or already partially or largely present as protein hydrolysates. Preference is given to a pearl extract in which conchiolin and albuminoid are already partially hydrolyzed.
  • the essential amino acids of these proteins are glutamic acid, serine, alanine, glycine aspartic acid and phenylalanine.
  • the bead extract is additionally enriched with at least one or more of these amino acids these amino acids.
  • the pearl extract is enriched with glutamic acid, serine and leucine.
  • a preferred extract contains organic and / or inorganic calcium salts as well as magnesium and sodium salts, inorganic silicon compounds and / or phosphates.
  • a most preferred pearl extract contains at least 75%, preferably 85%, more preferably 90% and most preferably 95% of all ingredients of the naturally occurring pearls.
  • pearl extracts according to the invention are the commercial products Pearl Protein Extract BG ® or Crodarom ® Pearl.
  • one of the above-described pearl extracts is contained in an amount of at least 0.01 to 20% by weight.
  • amounts of the extract of 0.01 to 10 wt.%, Very particularly preferably amounts of 0.01 to 5 wt.% Based on the total cosmetic composition used.
  • the fourth class of substances which is contained in the synergistic combination of active substances (A) according to the invention as an alternative to the vitamins, vitamin precursors and their derivatives (K) and the plant extracts (L) and the other proteins (P) are the silicone oils (S).
  • Silicone oils cause a wide variety of effects. For example, at the same time they influence the dry and wet combability, the grip of dry and wet hair and the shine.
  • the term silicone oils is understood by the person skilled in the art to mean several structures of organosilicon compounds. First of all, this is understood to mean the dimethiconols (S1). Dimethiconols form the first group of silicones which are particularly preferred according to the invention.
  • the dimethiconols according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethiconols can be represented by the following structural formula (S 1 - 1): (SiOHP ⁇ ) - O - (SiR 2 2 - O -) x - (SiOHR 1 ;,) (S 1 - 1)
  • Branched dimethiconols can be represented by the structural formula (S1-II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each independently run from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cps, very particularly preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the dimethiconols may already be present as an emulsion.
  • the corresponding emulsion of the dimethiconols can be prepared both after the preparation of the corresponding dimethiconols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of the dimethiconols can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.
  • the droplet size of the emulsified particles according to the invention is from 0.01 ⁇ m to 10000 ⁇ m, preferably from 0.01 to 100 ⁇ m, very particularly preferably from 0.01 to 20 ⁇ m and most preferably from 0.01 to 10 ⁇ m.
  • the particle size is determined by the method of light scattering.
  • branched dimethiconols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethiconols are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethiconols can be very particularly preferred.
  • Examples of such products include the following commercial products: Botanisil NU-150M (Botanigenics), Dow Coming 1-1254 Fluid, Dow Corning 2-9023 Fluid, Dow Corning 2-9026 Fluid, Ultrapure Dimethiconol (Ultra Chemical), Unisil SF- R (Universal Preserve), X-21-5619 (Shin-Etsu Chemical Co.), Abil OSW 5 (Degussa Care Specialties), ACC DL-9430 Emulsion (Taylor Chemical Company), AEC Dimethiconol & Sodium Dodecylbenzenesulfonate (A & E Connock (Perfumery & Cosmetics) Ltd.), BC Dimethiconol Emulsion 95 (Basildon Chemical Company, Ltd.), Cosmetic Fluid 1401, Cosmetic Fluid 1403, Cosmetic Fluid 1501, Cosmetic Fluid 1401DC (all aforementioned Chemsil Silicones, Inc.), Dow Corning 1401 Fluid, Dow Corning 1403 Fluid, Dow Corning 1501 Fluid, Dow Corning 1784 HVF
  • these compositions contain from 0.01 to 10% by weight, preferably from 0.1 to 8% by weight, more preferably from 0.25 to 7.5% by weight, and especially from 0 , 5 to 5 wt.% Dimethiconol based on the composition.
  • the use of the dimethiconols (S1) in the active substance composition (2) is preferred.
  • the dimethiconols (S1) can be used as the sole component of the active ingredient composition (2).
  • Dimethicones (S2) form the second group of silicones, which are particularly preferred according to the invention.
  • the dimethicones according to the invention can be both linear and branched as well as cyclic or cyclic and branched.
  • Linear dimethicones can be represented by the following structural formula (S2 - 1):
  • Branched dimethicones can be represented by the structural formula (S2 - II):
  • the radicals R 1 and R 2 are each independently hydrogen, a methyl radical, a C 2 to C 30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, Decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 -, -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3) C (O) OCH 2 -, - (CH 2) 3 CC (O) OCH 2 CH 2 -, -C 6 H 4C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • R 1 and R 2 are methyl, phenyl and C 2 to C 22 alkyl radicals. Of the C2 to C22 alkyl radicals, lauryl, stearyl and behenyl radicals are particularly preferred.
  • the numbers x, y and z are integers and each independently run from 0 to 50,000.
  • the molecular weights of Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are 1000-5000000 cPs, most preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the dimethicones may already be present as an emulsion.
  • the corresponding emulsion of the dimethicones can be prepared both after the preparation of the corresponding dimethicones from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicones can also be prepared directly by an emulsion polymerization process. Such methods are also well known to the person skilled in the art. For example, reference may be made to the Encyclopedia of Polymer Science and Engineering, Volume 15, Second Edition, pages 204 to 308, John Wiley & Sons, Inc. 1989. This reference is expressly incorporated herein by reference.
  • the droplet size of the emulsified particles according to the invention is 0.0 l ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering. If branched dimethicones are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly. For the purposes of the present invention, branched dimethicones are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes. According to the invention, both low-branched and highly branched dimethicones can be very particularly preferred.
  • these compositions contain from 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and especially 0 , 5 to 5 wt.% Dimethiconol based on the composition.
  • the use of the dimethicones (S2) in the active ingredient composition (2) is preferred.
  • the dimethicones (S2) can be used as the sole component of the active ingredient composition (2).
  • Dimethicone copolyols (S3) form another group of preferred silicones.
  • Dimethiconols can be represented by the following structural formulas:
  • the radicals R and R are each independently hydrogen, a methyl radical, a C2 to C30 linear, saturated or unsaturated hydrocarbon radical, a phenyl radical and / or an aryl radical.
  • the groups represented by R 1 and R 2 include alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, isopentyl, neopentyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-brom
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, - CH 2 CH 2 OCH 2 - , -OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and (CH 2) C (O) SCH 2 CH 2 - are preferred as R 1 and R 2 are methyl, phenyl and C 2 - to C 22 -alkyl radicals.
  • the numbers x, y and z are integers and each independently run from 0 to 50,000 Dimethicone lie between 1,000 D and 10000000 D.
  • the viscosities are between 100 and 10,000,000 cPs measured at 25 0 C by means of a glass capillary viscometer according to Dow Corning Corporate Test Method CTM 0004 dated 20 July 1970.
  • Preferred viscosities are from 1000 to 5,000,000 cps, most particularly preferred viscosities are between 10,000 and 3,000,000 cps. The most preferred range is between 50,000 and 2,000,000 cps.
  • the teaching of the invention also includes that the Dimethiconcopolymere can already be present as an emulsion.
  • the corresponding emulsion of the dimethicone copolyols can be prepared both after the preparation of the corresponding dimethicone copolyols from these and the usual methods of emulsification known to the person skilled in the art.
  • both cationic, anionic, nonionic or zwitterionic surfactants and emulsifiers can be used as auxiliaries for the preparation of the corresponding emulsions.
  • the emulsions of dimethicone copolyols can also be prepared directly by an emulsion polymerization process.
  • the droplet size of the emulsified particles is according to the invention 0.0 l ⁇ m to 10000 ⁇ m, preferably 0.01 to 100 ⁇ m, very particularly preferably 0.01 to 20 ⁇ m and most preferably 0.01 to 10 microns.
  • the particle size is determined by the method of light scattering.
  • branched dimethicone copolyols are used, it is to be understood that the branching is greater than a random branching, which occurs by impurities of the respective monomers randomly.
  • branched dimethicone copolyols are therefore to be understood as meaning that the degree of branching is greater than 0.01%.
  • a degree of branching is greater than 0.1%, and most preferably greater than 0.5%.
  • the degree of branching is determined from the ratio of unbranched monomers, that is, the amount of monofunctional siloxane, to the branching monomers, that is, the amount of tri- and tetrafunctional siloxanes.
  • both low-branched and highly branched dimethicone copolyols can be very particularly preferred.
  • these compositions contain from 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight and especially 0 , 5 to 5 wt.% Dimethiconecopolyol based on the composition.
  • the use of the dimethicone copolyols (S3) in the active substance composition (2) is preferred according to the invention.
  • the dimethicone copolyols (S3) can be used as the sole component of the active ingredient composition (2).
  • Aminofunctional silicones or also called amodimethicones (S4), are silicones which have at least one (optionally substituted) amino group.
  • Such silicones may e.g. by the formula (S4-1)
  • R is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms
  • Q is a polar radical of the general formula -R 1 HZ, wherein R 1 is a divalent connecting group attached to hydrogen and the Z is an organic, amino-functional radical containing at least one amino-functional group, carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms; "a" values in the range of about 0 to about 2, "b” assumes values in the range of about 1 to about 3, “a” + “b” is less than or equal to 3, and "c” is a number in the range of about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000, preferably from about 125 to about 10,000 and most preferably from about 150 to about 1000, and M is a suitable silicone end group as known in the
  • Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur containing radicals such as mercaptoethyl, mercaptopropyl,
  • R 1 examples include methylene, ethylene, propylene, hexamethylene, decamethylene, CH 2 CH (CH 3 ) CH 2 -, phenylene, naphthylene, -CH 2 CH 2 SCH 2 CH 2 -, -CH 2 CH 2 OCH 2 -, - OCH 2 CH 2 -, -OCH 2 CH 2 CH 2 -, -CH 2 CH (CH 3 ) C (O) OCH 2 -, - (CH 2 ) 3 CC (O) OCH 2 CH 2 -, - C 6 H 4 C 6 H 4 -, -C 6 H 4 CH 2 C 6 H 4 -; and - (CH 2 ) 3 C (O) SCH 2 CH 2 -.
  • Z is an organic, amino-functional radical containing at least one functional amino group.
  • a possible formula for Z is NH (CH 2 ) Z NH 2 , wherein z is 1 or more.
  • Another possible formula for Z is -NH (CH 2 ) Z (CH 2 ) zz NH, wherein both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl.
  • Z is most preferably a -NHCH 2 CH 2 NH 2 radical.
  • Z is -N (CH 2 ) Z (CH 2 ) Zz NX 2 or -NX 2 , wherein each X of X 2 is independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.
  • Q is most preferably a polar, amino-functional radical of the formula - CH 2 CH 2 CH 2 NHCH 2 CH 2 NH 2 .
  • "a" assumes values in the range of about 0 to about 2
  • "b” assumes values in the range of about 2 to about 3
  • "a" + "b” is less than or equal to 3
  • the molar ratio of the R a Q b SiO ( 4-ab ) / 2 units to the R 0 SiO (. ⁇ - units is in the range of about 1: 2 to 1: 65, preferably from about 1: 5 to about 1: 65, and most preferably from about 1: 15 to about 1: 20. If one or more silicones of the above formula are used then the various variable substituents in the above formula may be used different silicone components present in the silicone blend.
  • Preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-II)
  • G is -H, a phenyl group, -OH, -O-CH 3 , -CH 3 , -CH 2 CH 3 , -CH 2 CH 2 CH 3 , -
  • a is a number between 0 and 3, in particular 0; b stands for a number between 0 and 1, in particular 1, m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of
  • R ' is a monovalent radical selected from o -N (R ") - CH 2 -CH 2 - N (R") 2 o -N (R ") 2 -N o + (R ") 3 A ⁇ o -N + H (R") 2 A- o -N + H 2 (R ") A " o -N (R ”) - CH 2 -CH 2 -N + R” H 2 A " , where each R" is identical or different radicals from the group - H, -phenyl, -benzyl, the Ci -20 -alkyl radicals , preferably -CH 3 , - CH 2 CH 3 , -CH 2 CH 2 CH 3 , -CH (CH 3 ) 2 , -CH 2 CH 2 CH 2 H 3 , -CH 2 CH (CH 3 ) 2 , -CH (CH 3 ) CH 2 CH 3 , -C (CH 3 ) 3 ,
  • Particularly preferred agents according to the invention are characterized in that they contain an amino-functional silicone of the formula (S4-III)
  • n and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.
  • silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.
  • agents according to the invention which are characterized in that they contain an amino-functional silicone of the formula (S4-IV)
  • nl and n2 are numbers whose sum (m + nl + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (nl + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.
  • silicones are referred to as amodimethicones according to the INCI declaration.
  • agents according to the invention are preferred in which the amino-functional silicone has an amine number above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g ,
  • the amine number stands for the milliequivalent amine per gram of amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.
  • these compositions contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight, and especially 0 , 5 to 5 wt.% Amodimethicone based on the composition.
  • the use of the amodimethicones (S4) in the active substance composition (2) is preferred according to the invention.
  • the amodimethicones (S4) can be used as the sole component of the active ingredient composition (2).
  • the invention also encompasses the finding that a mixture of at least 2 different silicones can be used in the compositions (1 and 2) according to the invention.
  • Preferred mixtures of different silicones are, for example, dimethicones and dimethiconols, linear dimethicones and cyclic dimethiconols.
  • a very particularly preferred mixture of silicones consists of at least one cyclic dimethiconol and / or dimethicone, at least one further noncyclic dimethicone and / or dimethiconol and at least one amino-functional silicone. If different silicones are used as a mixture, the mixing ratio is largely variable.
  • silicones used for mixing are used in a ratio of 5: 1 to 1: 5 in the case of a binary mixture.
  • a ratio of 3: 1 to 1: 3 is particularly preferred.
  • Very particularly preferred mixtures contain all the silicones contained in the mixture largely in a ratio of about 1: 1, in each case based on the amounts used in wt.%.
  • these compositions contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, more preferably 0.25 to 7.5% by weight, and especially 0.5 to 5% by weight of silicone mixture based on the composition.
  • the use of the mixture of different silicones in the active ingredient composition (2) is preferred.
  • the mixture of silicones may be used as the sole component of the active ingredient composition (2).
  • both silicone polymers, dimethiconols and amodimethicones can be used together with the imidazolinium compounds of the formula I.
  • the Mixing ratio of the two silicone polymers is 99: 1 to 1: 99.
  • Agents preferred according to the invention contain, based on the weight of the composition, 0.01 to 10 wt.%, Preferably 0.1 to 8 wt.%, Particularly preferably 0.25 to 7.5 wt.% And in particular 0.5 to 5 % By weight of such a mixture of the invention
  • a particular application feature, which simultaneously contributes to a cosmetic and aesthetic overall appearance of the present invention, is that the active substance complex (A), and simultaneously, depending on the composition and composition of the composition of one or two compositions, a valuable and interesting overall visual appearance
  • Mixing the optionally separated compositions (Al and (A2) causes the pearl powder to dissolve and contribute to the formation of a particularly fine creamy, velvety soft and extremely pleasantly silky glossy foam
  • This foam can be obtained by the use of surfactants and / or Emulsifiers in the respective compositions result from the fact that, in particular, the calcium carbonates of the pearl powder dissolve in the acidic pH range, as a result of which carbon dioxide is liberated, which in turn foams the surfactants and / or emulsifiers Components of the composition / s, the cosmetic effect and the desired behavior of the active ingredient complex can be further targeted.
  • the action of the active ingredient complex (A) according to the invention by fatty substances (D) can be further increased.
  • Fatty substances are to be understood as meaning fatty acids, fatty alcohols, natural and synthetic waxes, which can be in solid form as well as liquid in aqueous dispersion, and natural and synthetic cosmetic oil components.
  • fatty acids (DI) it is possible to use linear and / or branched, saturated and / or unsaturated fatty acids having 6 to 30 carbon atoms. Preference is given to fatty acids having 10 to 22 carbon atoms.
  • isostearic as the commercial products Emersol ® 871 and Emersol ® 875
  • isopalmitic acids such as the commercial product Edenor ® IP 95
  • all other products sold under the trade names Edenor ® (Cognis) fatty acids were, for example, to name the isostearic as the commercial products Emersol ® 871 and Emersol ® 875, and isopalmitic acids such as the commercial product Edenor ® IP 95, and all other products sold under the trade names Edenor ® (Cognis) fatty acids.
  • fatty acids are caproic acid, caprylic acid, 2-ethylhexanoic acid, capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, elaeostearic acid, arachidic acid, gadoleic acid, behenic acid and erucic acid and their technical mixtures, which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxo synthesis or the dimerization of unsaturated fatty acids.
  • Particularly preferred are usually the fatty acid cuttings obtainable from coconut oil or palm oil; In particular, the use of stearic acid is usually preferred.
  • the amount used is 0.1 - 15 wt.%, Based on the total mean.
  • the amount is preferably 0.5-10% by weight, with amounts of 1-5% by weight being particularly advantageous.
  • Fatty alcohols (D2) may be used are saturated, mono- or polyunsaturated, branched or un branched fatty alcohols having C 6 - C 30 -, preferably C 0 - C 22 - and particularly preferably C 2 - C 22 - carbon atoms.
  • Decanols, octanols, dodecadienol, decadienol, oleyl alcohol, eruca alcohol, ricinoleic alcohol, stearyl alcohol, isostearyl alcohol, cetyl alcohol, lauryl alcohol, myristyl alcohol, arachidyl alcohol, caprylic alcohol, capric alcohol, linoleyl alcohol, linolenyl alcohol and behenyl alcohol are, for example, decanol, octanolol, dodecadienol, decadienol , as well as their Guerbet alcohols, this list should have exemplary and non-limiting character.
  • the fatty alcohols are derived from preferably natural fatty acids, which can usually be based on recovery from the esters of fatty acids by reduction.
  • the invention can also be used are those fatty alcohol cuts by reducing naturally occurring triglycerides such as beef tallow, palm oil, peanut oil, rapeseed oil, Baumwollsaä ⁇ öf; Soybean oil, sunflower oil and linseed oil or produced from their transesterification products with corresponding alcohols resulting fatty acid esters, and thus represent a mixture of different fatty alcohols.
  • Such substances are, for example, under the names Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®, for example, Lorol ® C8, Lorol C 14 ®, ® Lorol C 18, Lorol ® C8-18, HD Ocenol ®, Crodacol ® such as Crodacol ® CS, Novol ®, Eutanol ® G, Guerbitol ® 16, Guerbitol ® 18, Guerbitol ® 20, Isofol ® 12, Isofol ® 16, Isofol ® 24, Isofol ® 36, Isocarb ® 12, Isocarb ® 16 or Isocarb ® 24 for sale.
  • Stenol ® such as Stenol ® 1618 or Lanette ® such as Lanette ® O or Lorol ®
  • Lorol ® C8 Lorol C8-18
  • the invention also wool wax alcohols, as are commercially available, for example under the names of Corona ®, White Swan ®, Coronet ® or Fluilan ® can be used.
  • the fatty alcohols are used in amounts of from 0.1 to 30% by weight, based on the total preparation, preferably in amounts of from 0.1 to 20% by weight.
  • waxes As natural or synthetic waxes (D3) it is possible according to the invention to use solid paraffins or isoparaffins, carnauba waxes, beeswaxes, candelilla waxes, ozokerites, ceresin, spermaceti, sunflower wax, fruit waxes such as, for example, apple wax or citrus wax, microwaxes of PE or PP.
  • Such waxes are available, for example, from Kahl & Co., Trittau.
  • the amount used is 0.1-50% by weight, based on the total agent, preferably 0.1
  • the natural and synthetic cosmetic oil bodies (D4) which can increase the action of the active ingredient complex (A) according to the invention, include, for example:
  • oils examples include sunflower oil, olive oil, soybean oil, rapeseed oil, almond oil, jojoba oil, orange oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil. Also suitable, however, are other triglyceride oils such as the liquid portions of beef tallow as well as synthetic triglyceride oils.
  • the compounds are available as commercial products l, 3-di- (2-ethyl-hexyl) -cyclohexane (Cetiol ® S), and di-n-octyl ether (Cetiol OE) may be preferred.
  • Ester oils are to be understood as meaning the esters of C 6 - C 30 fatty acids with C 2 - C 30 fatty alcohols.
  • the monoesters of the fatty acids with alcohols having 2 to 24 carbon atoms are preferred.
  • Examples of fatty acid components used in the esters are caproic, caprylic, 2-ethylhexanoic, capric, lauric, isotridecanoic, myristic, palmitic, palmitoleic, stearic, isostearic, oleic, elaidic, petroselic, linoleic, linolenic Behenic acid and erucic acid and their technical mixtures which are obtained, for example, in the pressure splitting of natural fats and oils, in the oxidation of aldehydes from Roelen's oxo synthesis or the dimerization of unsaturated fatty acids.
  • fatty alcohol moieties in the ester oils are isopropyl alcohol, caproic alcohol, capryl alcohol, 2-ethylhexyl alcohol, capric alcohol, lauryl alcohol, isotridecyl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, linolyl alcohol, linolenyl alcohol, elaeostearyl alcohol, arachyl alcohol, gadoleyl alcohol, Behenyl alcohol, erucyl alcohol and Brassidylalkohol and their technical mixtures, for example, in the high-pressure hydrogenation of technical methyl esters based on fats and oils or aldehydes from the Roelen oxo synthesis and as a monomer fraction in the dimerization of unsaturated fatty alcohols incurred.
  • Erf ⁇ ndungsillet are particularly preferably isopropyl myristate (IPM Rilanit ®), isononanoic acid C16-18 alkyl ester (Cetiol ® SN), 2-ethylhexyl palmitate (Cegesoft ® 24), stearic acid-2-ethylhexyl ester (Cetiol ® 868), cetyl oleate, glycerol tricaprylate, Kokosfettalkohol- caprate / caprylate (Cetiol ® LC), n-butyl stearate, oleyl erucate (Cetiol ® J 600), isopropyl palmitate (Rilanit ® IPP), Oleyl Oleate (Cetiol ®), hexyl laurate (Cetiol ® A), di-n-butyl adipate (Cetiol ® B
  • Dicarboxylic acid esters such as di-n-butyl adipate, di (2-ethylhexyl) adipate, di- (2-ethylhexyl) succinate and di-isotridecylvestat, and diol esters such as ethylene glycol dioleate, ethylene glycol diisotridecanoate, propylene glycol di (2 ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonat, butanediol di-isostearate, Neopentylglykol- dicaprylate, symmetrical, asymmetric or cyclic esters of carbonic acid with fatty alcohols, for example described in DE-OS 197 56 454, glycerol carbonate or dicaprylyl carbonate (Cetiol ® CC),
  • Fatty acid partial glycerides ie monoglycerides, diglycerides and their technical mixtures. With the use of technical products production reasons may still contain small amounts of triglycerides.
  • the partial glycerides preferably follow the formula (D4-I), CH 2 O (CH 2 CH 2 O) 01 R 1
  • R 3 in the R 1 , R 2 and R 3 is independently of one another hydrogen or a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22, preferably 12 to 18, Carbon atoms are provided with the proviso that at least one of these groups is an acyl radical and at least one of these groups is hydrogen.
  • the sum (m + n + q) is 0 or numbers from 1 to 100, preferably 0 or 5 to 25.
  • R 1 is an acyl radical and R 2 and R 3 are hydrogen and the sum (m + n + q) is 0.
  • Typical examples are mono- and / or diglycerides based on caproic acid, caprylic acid, 2-ethylhexanoic acid, Capric acid, lauric acid, isotridecanoic acid, myristic acid, palmitic acid, palmitic acid, stearic acid, isostearic acid, oleic acid, elaidic acid, petroselinic acid, linoleic acid, linolenic acid, elaeo stearic acid, arachic acid, gadoleic acid, behenic acid and erucic acid, and technical mixtures thereof.
  • oleic acid monoglycerides are used.
  • the amount used of the natural and synthetic cosmetic oil bodies in the compositions used according to the invention is usually 0.1 to 30% by weight, based on the total composition, preferably 0.1 to 20% by weight, and in particular 0.1 to 15% by weight. -%.
  • the total amount of oil and fat components in the compositions according to the invention is usually 0.5-75% by weight, based on the total agent. Amounts of 0.5-35 wt .-% are preferred according to the invention.
  • the agents used according to the invention comprise surfactants.
  • surfactants is understood as meaning surface-active substances which form adsorption layers on the upper and boundary surfaces or which can aggregate in volume phases to give micelle colloids or lyotropic mesophases.
  • anionic surfactants consisting of a hydrophobic radical and a negatively charged hydrophilic head group
  • amphoteric surfactants which carry both a negative and a compensating positive charge
  • cationic surfactants which, in addition to a hydrophobic radical, have a positively charged hydrophilic group
  • nonionic surfactants which have no charges but strong dipole moments and are highly hydrated in aqueous solution.
  • Suitable anionic surfactants (E1) in preparations according to the invention are all anionic surfactants suitable for use on the human body. These are characterized by a water-solubilizing, anionic group such as. Example, a carboxylate, sulfate, sulfonate or phosphate group and a lipophilic alkyl group having about 8 to 30 carbon atoms. In addition, glycol or polyglycol ether groups, ester, ether and amide groups and hydroxyl groups may be present in the molecule. Examples of suitable anionic surfactants are, in each case in the form of the sodium, potassium and ammonium as well as the mono-, di- and trialkanolammonium salts having 2 to 4 C atoms in the alkanol group,
  • Alkyl group having 8 to 30 C atoms and x 0 or 1 to 16,
  • Sulfobernsteinklamono- and dialkyl ester having 8 to 24 carbon atoms in the alkyl group and sulfosuccinic monoalkylpolyoxyethylester having 8 to 24 carbon atoms in the alkyl group and 1 to 6 oxyethyl groups, linear alkanesulfonates having 8 to 24 carbon atoms, linear alpha-olefinsulfonates with 8 to 24 carbon atoms,
  • Alpha-sulfofatty acid methyl esters of fatty acids having 8 to 30 C atoms are alpha-sulfofatty acids having 8 to 30 C atoms
  • Alkyl sulfates and alkyl polyglycol ether sulfates of the formula RO (CH 2 -CH 2 O) x -OSO 3 H, in which R is a preferably linear alkyl group having 8 to 30 C atoms and x 0 or 1 to 12,
  • R 1 is preferably an aliphatic hydrocarbon radical having 8 to 30 carbon atoms
  • R 2 is hydrogen, a radical (CH 2 CH 2 O) n R 2 or X
  • n is from 1 to 10
  • X is hydrogen, an alkali metal radical or alkaline earth metal or NR 3 R 4 R 5 R 6 , where R 3 to R 6 independently of one another represent hydrogen or a C 1 to C 4 hydrocarbon radical, is a sulfated fatty acid alkylene glycol ester of the formula (II) R 7 CO (Al k O) n SO 3 M (El-II) in the R 7 CO- for a linear or branched, aliphatic, saturated and / or unsaturated acyl radical having 6 to 22 C atoms, Alk for CH 2 CH 2 , CHCH 3 CH 2 and / or CH 2 CHCH 3 , n is from 0.5 to 5 and M is a cation as described in DE-OS 197 36 906.5,
  • (El-III) in the R 8 CO for a linear or branched acyl radical having 6 to 22 carbon atoms, x, y and z in total for O or for numbers from 1 to 30, preferably 2 to 10, and X for an alkali metal or alkaline earth metal.
  • Typical examples of monoglyceride (ether) sulfates suitable for the purposes of the invention are the reaction products of lauric acid monoglyceride, coconut fatty acid monoglyceride, palmitic acid monoglyceride, stearic acid monoglyceride, oleic acid monoglyceride and tallow fatty acid monoglyceride and their ethylene oxide adducts with sulfur trioxide or chlorosulfonic acid Form of their sodium salts.
  • monoglyceride sulfates of the formula (III-III) are used in which R 8 CO is a linear acyl radical having 8 to 18 carbon atoms, as described, for example, in EP-B1 0 561 825, EP-B1 0 561 999, DE -Al 42 04 700 or by AKBiswas et al. in J.Am.Oil. Chem. Soc. 37, 171 (1960) and FUAhmed in J.Am.Oil.Chem.Soc. 67, 8 (1990),
  • Preferred anionic surfactants are alkyl sulfates, alkyl polyglycol ether sulfates and ether carboxylic acids having 10 to 18 C atoms in the alkyl group and up to 12 glycol ether groups in the molecule, sulfosuccinic acid mono- and dialkyl esters having 8 to 18 C atoms in the alkyl group and sulfosuccinic acid monoalkylpolyoxyethylester with 8 to 18 C atoms in the alkyl group and 1 to 6 oxyethyl groups, Monoglycerdisulfate, alkyl and Alkenyletherphosphate and protein fatty acid condensates.
  • Zwitterionic surfactants are those surface-active compounds which carry at least one quaternary ammonium group and at least one -COO (") or -SO 3 (") group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as N-alkyl-N, N-dimethylammonium glycinates, for example cocoalkyl dimethylammonium glycinate, N-acylaminopropyl N, N-dimethylammonium glycinates, for example cocoacylaminopropyl dimethylammonium glycinate, and 2-alkyl 3-carboxymethyl-3-hydroxyethyl-imidazolines having in each case 8 to 18 C atoms in the alkyl or acyl group, and also the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • a preferred zwitterionic surfactant is the fatty acid amide derivative known by the INCI name Cocamidopropyl Betaine.
  • Ampholytic surfactants (E3) are understood as meaning those surface-active compounds which contain, apart from a C 8 -C 24 -alkyl or -acyl group in the molecule, at least one free amino group and at least one -COOH or -SO 3 H-group and for formation internal salts are capable.
  • suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate and C 12 -C 8 -acylsarcosine.
  • Nonionic surfactants (E4) contain as hydrophilic group e.g. a polyol group, a polyalkylene glycol ether group or a combination of polyol and polyglycol ether group. Such compounds are, for example
  • alkoxylated fatty acid alkyl esters of the formula (E4-I) R'CO- (OCH 2 CHR 2 ) W OR 3 (E4-I)
  • R is CO for a linear or branched, saturated and / or unsaturated acyl radical having 6 to 22 carbon atoms
  • R 2 is hydrogen or methyl
  • R 3 is linear or branched alkyl radicals having 1 to 4 carbon atoms and w is a number from 1 to 20 , Amine oxides,
  • Hydroxy mixed ethers as described, for example, in DE-OS 19738866, sorbitan fatty acid esters and addition products of ethylene oxide onto sorbitan fatty acid esters, for example the polysorbates,
  • R 4 is an alkyl or alkenyl radical having 4 to 22 carbon atoms
  • G is a sugar radical having 5 or 6 carbon atoms
  • p is a number from 1 to 10.
  • the alkyl and alkenyl oligoglycosides can be derived from aldoses or ketoses with 5 or 6 carbon atoms, preferably glucose.
  • the preferred alkyl and / or alkenyl oligoglycosides are thus alkyl and / or alkenyl oligoglucosides.
  • the index number p in the general formula (E4-II) indicates the degree of oligomerization (DP), ie the distribution of mono- and oligoglycosides, and stands for a number between 1 and 10.
  • the alkyl or alkenyl radical R 4 can be derived from primary alcohols having 4 to 11, preferably 8 to 10 carbon atoms. Typical examples are butanol, caproic alcohol, caprylic alcohol, capric alcohol and undecyl alcohol and their technical mixtures, as obtained, for example, in the hydrogenation of technical fatty acid methyl esters or in the hydrogenation of aldehydes from Roelen's oxosynthesis.
  • the alkyl or alkenyl radical R 15 can also be derived from primary alcohols having 12 to 22, preferably 12 to 14 carbon atoms.
  • Typical examples are lauryl alcohol, myristyl alcohol, cetyl alcohol, palmoleyl alcohol, stearyl alcohol, isostearyl alcohol, oleyl alcohol, elaidyl alcohol, petroselinyl alcohol, arachyl alcohol, gadoleyl alcohol, behenyl alcohol, erucyl alcohol, brassidyl alcohol, and technical mixtures thereof which can be obtained as described above.
  • Preference is given to alkyl oligoglucosides based on hydrogenated C 12 / H coconut alcohol having a DP of 1 to 3.
  • R 6 is hydrogen, an alkyl or hydroxyalkyl radical having 1 to 4 carbon atoms and [Z] represents a linear or branched polyhydroxyalkyl radical having 3 to 12 carbon atoms and 3 to 10 hydroxyl groups.
  • the fatty acid N-alkyl polyhydroxyalkylamides are known substances which can usually be obtained by reductive amination of a reducing sugar with ammonia, an alkylamine or an alkanolamine and subsequent acylation with a fatty acid, a fatty acid alkyl ester or a fatty acid chloride. With regard to the processes for their preparation, reference may be made to US Pat. Nos.
  • the fatty acid N-alkylpolyhydroxyalkylamides are preferably derived from reducing sugars having 5 or 6 carbon atoms, in particular from glucose.
  • the preferred fatty acid N-alkylpolyhydroxyalkylamides are therefore fatty acid N-alkylglucamides as represented by the formula (E4-IV):
  • the fatty acid N-alkylpolyhydroxyalkylamides used are preferably glucamides of the formula (E4-IV) in which R 8 is hydrogen or an alkyl group and R 7 is CO for the acyl radical of caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitic acid, Stearic acid, isostearic acid, oleic acid, elaidic acid, petroselic acid, linoleic acid, linolenic acid, arachidic acid, gadoleic acid, behenic acid or erucic acid or their technical mixtures.
  • R 8 is hydrogen or an alkyl group
  • R 7 is CO for the acyl radical of caproic acid, caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitic acid, Stearic acid, isostearic acid, oleic acid, elaidic acid, petroselic acid
  • fatty acid N-alkylglucamides of the formula (E4-IV) which are obtained by reductive amination of glucose with methylamine and subsequent acylation with lauric acid or C 12/14 coconut fatty acid or a corresponding derivative.
  • the polyhydroxyalkylamides can also be derived from maltose and palatinose.
  • Preferred nonionic surfactants are the alkylene oxide addition products of saturated linear fatty alcohols and fatty acids each having 2 to 30 moles of ethylene oxide per Mol fatty alcohol or fatty acid proven. Preparations having excellent properties are also obtained if they contain fatty acid esters of ethoxylated glycerol as nonionic surfactants.
  • the alkyl radical R contains 6 to 22 carbon atoms and may be both linear and branched. Preference is given to primary linear and methyl-branched in the 2-position aliphatic radicals.
  • Such alkyl radicals are, for example, 1-octyl, 1-decyl, 1-lauryl, 1-myristyl, 1-cetyl and 1-stearyl. Particularly preferred are 1-octyl, 1-decyl, 1-lauryl, 1-myristyl.
  • oxo-alcohols compounds with an odd number of carbon atoms in the alkyl chain predominate.
  • nonionic surfactants are the sugar surfactants. These may preferably be present in the agents used according to the invention in amounts of from 0.1 to 20% by weight, based on the total agent. Amounts of 0.5-15% by weight are preferred, and most preferred are amounts of 0.5-7.5% by weight.
  • the compounds used as surfactant with alkyl groups may each be uniform substances. However, it is generally preferred to use native vegetable or animal raw materials in the production of these substances, so that substance mixtures having different alkyl chain lengths depending on the respective raw material are obtained.
  • both products with a "normal” homolog distribution and those with a narrow homolog distribution can be used.
  • "normal” homolog distribution are meant mixtures of homologs obtained in the reaction of fatty alcohol and alkylene oxide using alkali metals, alkali metal hydroxides or alkali metal alcoholates as catalysts. Restricted homolog distributions are obtained when, for example, hydrotalcites, alkaline earth metal salts of Ethercarbonklaren, alkaline earth metal oxides, hydroxides or alcoholates are used as catalysts. The use of products with narrow homolog distribution may be preferred.
  • the surfactants (E) are used in amounts of 0.1-45% by weight, preferably 0.5-30% by weight and very particularly preferably 0.5-25% by weight, based on the total agent used according to the invention ,
  • quaternary ammonium compounds are ammonium halides, especially chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides, e.g.
  • the long alkyl chains of the above-mentioned surfactants preferably have 10 to 18 carbon atoms.
  • Esterquats are known substances which contain both at least one ester function and at least one quaternary ammonium group as a structural element.
  • Preferred ester quats are quaternized ester salts of fatty acids with triethanolamine, quaternized ester salts of fatty acids with diethanolalkylamines and quaternized ester salts of fatty acids with 1,2-dihydroxypropyldialkylamines.
  • Such products are marketed under the trade names Stepantex® ®, ® and Dehyquart® Armocare® ®.
  • the products Armocare ® VGH-70, a N, N-bis (2-Palmitoyloxy- ethyl) dimethyl ammonium chloride, as well as Dehyquart ® F-75, Dehyquart ® C-4046, Dehyquart ® L80 and Dehyquart ® AU-35 are examples of such esterquats .
  • the alkylamidoamines are usually prepared by amidation of natural or synthetic fatty acids and fatty acid cuts with dialkylaminoamines.
  • a According to the invention particularly suitable compound from this group is that available under the name Tegoamid ® S 18 commercially stearamidopropyl dimethylamine.
  • the cationic surfactants (E5) are contained in the agents used according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5 wt .-% are particularly preferred.
  • Anionic, nonionic, zwitterionic and / or amphoteric surfactants and mixtures thereof may be preferred according to the invention.
  • the effect of the active ingredient complex (A) according to the invention can be increased by emulsifiers (F).
  • Emulsifiers effect at the phase interface the formation of water- or oil-stable adsorption layers, which protect the dispersed droplets against coalescence and thus stabilize the emulsion.
  • Emulsifiers are therefore constructed like surfactants from a hydrophobic and a hydrophilic part of the molecule. Hydrophilic emulsifiers preferably form O / W emulsions and hydrophobic emulsifiers preferably form W / O emulsions.
  • An emulsion is to be understood as meaning a droplet-like distribution (dispersion) of a liquid in another liquid under the expense of energy in order to create stabilizing phase interfaces by means of surfactants.
  • the selection of these emulsifying surfactants or emulsifiers depends on the substances to be dispersed and the respective outer phase and the fineness of the emulsion. Further definitions and properties of emulsifiers can be found in "H.-D.Dörfler, Grenz inhabit- und Kolloidchemie, VCH Verlagsgesellschaft mbH, Weinheim, 1994".
  • Emulsifiers which can be used according to the invention are, for example
  • alkyl (oligo) glucosides for example, the commercially available product ® Montanov 68,
  • Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil Adducts of 5 to 60 moles of ethylene oxide with castor oil and hydrogenated castor oil
  • Sterols are understood to mean a group of steroids which have a hydroxyl group on C-atom 3 of the steroid skeleton and are isolated both from animal tissue (zoosterols) and from vegetable fats (phytosterols). Examples of zoosterols are cholesterol and lanosterol. Examples of suitable phytosterols are ergosterol, stigmasterol and sitosterol. Mushrooms and yeasts are also used to isolate sterols, the so-called mycosterols.
  • glucose phospholipids e.g. as lecithins or phosphatidylcholines from e.g. Egg yolk or plant seeds (e.g., soybeans) are understood.
  • Fatty acid esters of sugars and sugar alcohols such as sorbitol
  • Polyglycerols and polyglycerol derivatives such as polyglycerol poly-12-hy- droxystearat (Dehymuls ® PGPH commercial product)
  • Linear and branched fatty acids with 8 to 30 C atoms and their Na, K, ammonium, Ca, Mg and Zn salts.
  • the agents according to the invention preferably contain the emulsifiers in amounts of 0.1-25% by weight, in particular 0.5-15% by weight, based on the total agent.
  • the compositions according to the invention may preferably contain at least one nonionic emulsifier having an HLB value of 8 to 18, according to the methods described in the Römpp Lexikon Chemie (Hrg. J. Falbe, M. Regitz), 10th edition, Georg Thieme Verlag Stuttgart, New York, (1997), page 1764, listed definitions.
  • Nonionic emulsifiers having an HLB value of 10 to 15 may be particularly preferred according to the invention.
  • polymers (G) can support the action of the active ingredient complex (A) according to the invention.
  • polymers are added to the compositions used according to the invention, both cationic, anionic, amphoteric and nonionic polymers having proven effective.
  • Cationic polymers (G1) are polymers which have a group in the main and / or side chain which may be "temporary” or “permanent” cationic.
  • "permanently cationic” refers to those polymers which have a cationic group, irrespective of the pH of the agent. These are usually polymers containing a quaternary nitrogen atom, for example in the form of an ammonium group.
  • Preferred cationic groups are quaternary ammonium groups.
  • those polymers in which the quaternary ammonium group is bonded via a C 1-4 -hydrocarbon group to a polymer main chain constructed from acrylic acid, methacrylic acid or derivatives thereof have proven to be particularly suitable.
  • R 1 is -H or -CH 3
  • R 2 , R 3 and R 4 are independently selected from C 1-4 -alkyl, -alkenyl or -hydroxyalkyl groups
  • m 1, 2, 3 or 4
  • n is a natural number
  • X ' is a physiologically acceptable organic or inorganic anion, as well as copolymers consisting essentially of the monomer units listed in formula (GI-I) and nonionic monomer units are particularly preferred cationic polymers.
  • GI-I formula
  • nonionic monomer units are particularly preferred cationic polymers.
  • those are preferred according to the invention for which at least one of the following conditions applies:
  • R 1 is a methyl group
  • R 2 , R 3 and R 4 are methyl groups
  • m has the value 2.
  • Suitable physiologically tolerated counterions X " are, for example, halide ions, sulfate ions, phosphate ions, methosulfate ions and organic ions such as lactate, citrate, tartrate and acetate ions, preference being given to halide ions, in particular chloride.
  • a particularly suitable homopolymer is, if desired crosslinked, PolyCmethacryloyloxyethyltrimethylammoniurnchlorid) with the INCI name Polyquaternium-37.
  • the crosslinking can, if desired, be carried out with the aid of poly olefinically unsaturated compounds, for example divinylbenzene, tetraallyloxyethane, methylenebisacrylamide, diallyl ether, polyallylpolyglyceryl ethers, or allyl ethers of sugars or sugar derivatives such as erythritol, pentaerythritol, arabitol, mannitol, sorbitol, sucrose or glucose.
  • Methylenebisacrylamide is a preferred crosslinking agent.
  • the homopolymer is preferably used in the form of a nonaqueous polymer dispersion which should not have a polymer content of less than 30% by weight.
  • Such polymer dispersions are available under the names Salcare ® SC 95 (about 50% polymer content, additional components: mineral oil (INCI name: Mineral Oil) and tridecyl polyoxypropylene-polyoxyethylene-ether (INCI name: PPG-l-Trideceth- 6)), and Salcare ® SC 96 (about 50% polymer content, additional components: mixture of diesters of propylene glycol with a mixture of caprylic and capric acid (INCI name: Propylene glycol dicaprylates / dicaprate) and tridecyl polyoxypropylene polyoxyethylene ether (INCI name: PPG-l-trideceth-6)) are commercially available.
  • Copolymers containing monomer units according to formula (Gl-I) as non-ionic monomer preferably acrylamide, methacrylamide, acrylic acid-Ci -4 alkyl ester and methacrylic acid-Ci- 4 -alkyl.
  • the acrylamide is particularly preferred.
  • These copolymers can also be crosslinked, as described above in the case of the homopolymers.
  • a copolymer preferred according to the invention is the crosslinked acrylamide-methacryloyloxyethyltrimethylammonium chloride copolymer.
  • - Quaternized cellulose derivatives such as those under the names Celquat ® and Polymer JR ® commercially available.
  • the compounds Celquat ® H 100, Celquat ® L 200 and Polymer JR ® 400 are preferred quaternized cellulose derivatives, cationic alkyl polyglycosides according to DE-PS 44 13 686, cationized honey, for example the commercial product Honeyquat ® 50, cationic guar derivatives, such as in particular the products sold under the trade names Cosme- dia ® guar and Jaguar ® products,
  • Such compounds are sold under the names Gafquat ® 734 and Gafquat ® 755 commercially,
  • cationic polymers those known under the names Polyquaternium-24 (commercial product eg Quatrisoft LM 200).
  • copolymers of vinylpyrrolidone such as the commercial products Copolymer 845 (manufactured by ISP), Gaffix ® VC 713 (manufactured by ISP), Gafquat ® ASCP 101 1, Gafquat ® HS 1 10, Luviquat ® 8155 and Luviquat ® MS 370 are available.
  • cationic polymers are the so-called "temporary cationic" polymers. These polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • temporary cationic polymers usually contain an amino group which, at certain pH values, is present as quaternary ammonium group and thus cationic.
  • chitosan and its derivatives, such as 101 are freely available commercially, for example under the trade names Hydagen CMF ®, Hydagen HCMF ®, Kytamer ® PC and Chitolam ® NB /.
  • preferred cationic polymers are cationic cellulose derivatives and chitosan and its derivatives, in particular the commercial products Polymer JR 400, Hydagen HCMF ® and Kytamer ® PC, cationic guar derivatives, cationic honey deriva- derivatives, in particular the commercially available product ® Honeyquat 50, cationic Alkylpolyglycodside according to DE-PS 44 13 686, and polymers of the type Polyquaternium-37.
  • cationized protein hydrolyzates are to be counted among the cationic polymers, wherein the underlying protein hydrolyzate from the animal, for example from collagen, milk or keratin, from the plant, for example from wheat, corn, rice, potatoes, soy or almonds, marine life forms, for example from fish collagen or algae, or biotechnologically derived protein hydrolysates.
  • the protein hydrolyzates on which the cationic derivatives according to the invention are based can be obtained from the corresponding proteins by chemical, in particular alkaline or acid hydrolysis, by enzymatic hydrolysis and / or a combination of both types of hydrolysis.
  • cationic protein hydrolyzates are to be understood as meaning quaternized amino acids and mixtures thereof.
  • the quaternization of the protein hydrolyzates or amino acids is often carried out using quaternary ammonium salts such as N, N-dimethyl-N- (n-alkyl) -N- (2-hydroxy-3-chloro-n-propyl) ammonium halides.
  • the cationic protein hydrolysates may also be further derivatized.
  • the cationic protein hydrolyzates and derivatives according to the invention those mentioned under the INCI names in the "International Cosmetic Ingredient Dictionary and Handbook", (seventh edition 1997, The Cosmetic, Toiletry, and Fragrance Association 1101 17 ⁇ Street, NW, Suite 300 Cocodimium Hydroxypropyl Hydrolyzed Collagen, Cocodimopnium Hydroxypropyl Hydrolyzed Casein, Cocodimonium Hydroxypropyl Hydrolyzed Collagen, Cocodimonium Hydroxypropyl Hydrolyzed Hair Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Keratin, Cocodimonium Hydroxypropyl Hydrolyzed Rice Protein, Cocodimonium Hydroxypropyl Hydrolyzed Soy Protein, Cocodimonium Hydroxypropyl Hydrolyzed Wheat Protein, Hydroxypropyl Arginine Lauryl / Myristyl Ether HCl, Hydroxyprop
  • the anionic polymers (G2) which can promote the action of the active ingredient complex (A) according to the invention are anionic polymers which have carboxylate and / or sulfonate groups.
  • anionic monomers from which such polymers may consist are acrylic acid, methacrylic acid, crotonic acid, maleic anhydride and 2-acrylamido-2-methylpropanesulfonic acid.
  • the acidic groups may be used in whole or in part as sodium, potassium, ammonium, Mono- or triethanolammonium salt present.
  • Preferred monomers are 2-acrylamido-2-methylpropanesulfonic acid and acrylic acid.
  • Anionic polymers which contain 2-acrylamido-2-methylpropanesulfonic acid as the sole or co-monomer can be found to be particularly effective, it being possible for all or some of the sulfonic acid group to be present as sodium, potassium, ammonium, mono- or triethanolammonium salt ,
  • the homopolymer of 2-acrylamido-2-methyl propane sulfonic acid is, which is available commercially, for example under the name Rheothik ® 1 1-80.
  • copolymers of at least one anionic monomer and at least one nonionic monomer are preferable to use copolymers of at least one anionic monomer and at least one nonionic monomer.
  • anionic monomers reference is made to the substances listed above.
  • Preferred nonionic monomers are acrylamide, methacrylamide, acrylic esters, methacrylic esters, vinylpyrrolidone, vinyl ethers and vinyl esters.
  • Preferred anionic copolymers are acrylic acid-acrylamide copolymers and in particular polyacrylamide copolymers with sulfonic acid-containing monomers.
  • a particularly preferred anionic copolymer consists of 70 to 55 mol% of acrylamide and 30 to 45 mol% of 2-acrylamido-2-methylpropanesulfonic acid, wherein the sulfonic acid group is wholly or partly in the form of sodium, potassium, ammonium, mono- or triethanolammonium Salt is present.
  • This copolymer can also be present in crosslinked form, with preference being given to polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide as crosslinking agents.
  • polyolefinically unsaturated compounds such as tetraallyloxyethane, allylsucrose, allylpentaerythritol and methylenebisacrylamide as crosslinking agents.
  • Such a polymer is contained in the commercial product Sepigel ® 305 from SEPPIC.
  • the use of this compound, which in addition to the polymer component contains a hydrocarbon mixture (Ci 3 -C 4 isoparaffin) and a nonionic emulsifier (laureth-7), has proved to be particularly advantageous in the context of the teaching of the invention.
  • Simulgel ® 600 as a compound with isohexadecane and polysorbate-80 Nat
  • anionic homopolymers are uncrosslinked and crosslinked polyacrylic acids. Allyl ethers of pentaerythritol, sucrose and propylene may be preferred crosslinking agents. Such compounds are for example available under the trademark Carbopol ® commercially.
  • Copolymers of maleic anhydride and methyl vinyl ether are also color-retaining polymers.
  • a cross-linked with 1, 9-Decadiene-methyl vinyl ether maleic acid copolymer is available under the name ® Stabileze QM.
  • amphoteric polymers (G3) can be used as polymers for increasing the activity of the active ingredient complex (A) according to the invention.
  • amphoteric polymers includes both those polymers which contain in the molecule both free amino groups and free -COOH or SO 3 H groups and are capable of forming internal salts, as well as zwitterionic polymers which in the molecule have quaternary ammonium groups and -COO contain " - or -SO 3 " groups, and summarizes those polymers containing -COOH or SO 3 H groups and quaternary ammonium groups.
  • amphopolymer suitable is that available under the name Amphomer ® acrylic resin which is a copolymer of ethyl methacrylate tert-butylamino, N- (I 5 1, 3, 3-tetramethylbutyl) -acrylamide and two or more monomers from the group Acrylic acid, methacrylic acid and their simple esters.
  • Amphomer ® acrylic resin which is a copolymer of ethyl methacrylate tert-butylamino, N- (I 5 1, 3, 3-tetramethylbutyl) -acrylamide and two or more monomers from the group Acrylic acid, methacrylic acid and their simple esters.
  • amphoteric polymers are those polymers which are composed essentially
  • A is the anion of an organic or inorganic acid
  • the agents according to the invention may contain nonionic polymers (G4).
  • Suitable nonionic polymers are, for example:
  • Vinylpyrrolidone / vinyl ester copolymers as sold, for example, under the trademark Luviskol ® (BASF).
  • Luviskol ® VA 64 and Luviskol ® VA 73, each vinylpyrrolidone / vinyl acetate copolymers, are also preferred nonionic polymers.
  • Cellulose ethers such as hydroxypropyl cellulose, hydroxyethyl cellulose and hydroxypropylcellulose Methylhy- as for example under the trademark Culminal® ® and
  • Siloxanes These siloxanes can be both water-soluble and water-insoluble. Both volatile and nonvolatile siloxanes are suitable, nonvolatile siloxanes being understood as meaning those compounds whose boiling point is above 200 ° C. under normal pressure.
  • Preferred siloxanes are polydialkylsiloxanes, such as, for example, polydimethylsiloxane, polyalkylarylsiloxanes, such as, for example, polyphenylmethylsiloxane, ethoxylated polydialkylsiloxanes and polydialkylsiloxanes which contain amine and / or hydroxyl groups.
  • the preparations used contain a plurality of, in particular two different polymers of the same charge and / or in each case an ionic and an amphoteric and / or nonionic polymer.
  • the polymers (G) are contained in the agents used according to the invention preferably in amounts of 0.05 to 10 wt .-%, based on the total agent. Amounts of 0.1 to 5, in particular from 0.1 to 3 wt .-%, are particularly preferred.
  • the effect of the active substance complex (A) by UV filter (I) can be increased.
  • the UV filters to be used according to the invention are not subject to any general restrictions with regard to their structure and their physical properties. On the contrary, all UV filters which can be used in the cosmetics sector and whose absorption maximum lies in the UVA (315-400 nm), in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range are suitable. UV- Filters having an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the UV filters used according to the invention can be selected, for example, from substituted benzophenones, p-aminobenzoic acid esters, diphenylacrylic acid esters, cinnamic acid esters, salicylic acid esters, benzimidazoles and o-aminobenzoic acid esters.
  • UV filters which can be used according to the invention are 4-aminobenzoic acid, N 9 N 9 N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) aniline methylsulfate, 3,3,5-trimethylcyclohexyl salicylate (homosalates ), 2-hydroxy-4-methoxy-benzophenone (benzophenone-3; Uvinul ® M 40, Uvasorb MET ®, ® Neo Heliopan BB, Eusolex ® 4360), 2-Phenylbenzimida- zol-5-sulfonic acid and potassium, sodium - and triethanolamine (Phenylbenzimi- dazole sulfonic acid; Parsol ® HS; Neo Heliopan Hydro ®), 3,3 '- (l, 4-phenylenedimethylene) - bis (7,7-dimethyl-2-oxo-bicyclo [2.2.
  • water-insoluble UV filters are those which dissolve in water at not more than 1% by weight, in particular not more than 0.1% by weight, at 20 ° C. Furthermore, these compounds should be soluble in the usual cosmetic oil components at room temperature to at least 0.1, in particular at least 1 wt .-%).
  • the use of water-insoluble UV filters can therefore be preferred according to the invention.
  • UV filters have the general structure U - Q.
  • the structural part U stands for a UV-absorbing group.
  • this group can be derived from the known UV filters which can be used in the cosmetics sector, in which a group, generally a hydrogen atom, of the UV filter is protected by a cationic group Q, in particular having a quaternary amino function. is replaced.
  • Compounds from which the structural part U can derive are, for example
  • Structural parts U which are derived from cinnamic acid amide or from N, N-dimethylaminobenzoic acid amide, are preferred according to the invention.
  • the structural parts U can in principle be chosen such that the absorption maximum of the UV filters can be in both the UVA (315-400 nm) and in the UVB (280-315 nm) or in the UVC ( ⁇ 280 nm) range. UV filters with an absorption maximum in the UVB range, in particular in the range from about 280 to about 300 nm, are particularly preferred.
  • the structural part U also as a function of structural part Q, is preferably selected so that the molar extinction coefficient of the UV filter at the absorption maximum is above 15,000, in particular above 20,000.
  • the structural part Q preferably contains, as a cationic group, a quaternary ammonium group.
  • This quaternary ammonium group can in principle be connected directly to the structural part U, so that the structural part U represents one of the four substituents of the positively charged nitrogen atom.
  • one of the four substituents on the positively charged nitrogen atom is a group, especially an alkylene group of 2 to 6 carbon atoms, which functions as a compound between the structural portion U and the positively charged nitrogen atom.
  • the group Q has the general structure - (CH 2 ) X -N + R 1 R 2 R 3 X " , in which x is an integer from 1 to 4, R 1 and R 2 are independently of one another 4 alkyl groups, R 3 -22 alkyl group or a benzyl group and x 'is a physiologically acceptable anion of a Ci.
  • x is preferably the number 3
  • R 1 and R 2 each represent a methyl group and R 3 is either a methyl group or a saturated or unsaturated, linear or branched hydrocarbon chain having 8 to 22, in particular 10 to 18, carbon atoms.
  • Physiologically acceptable anions are, for example, inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.
  • inorganic anions such as halides, in particular chloride, bromide and fluoride, sulfate ions and phosphate ions and organic anions such as lactate, citrate, acetate, tartrate, methosulfate and tosylate.
  • Two preferred UV filters with cationic groups are the commercially available compounds cinnamic acid-trimethylammonium chloride (quat Incro- ® UV-283) and dodecyl tosylate (Escalol ® HP 610).
  • the teaching of the invention also includes the use of a combination of several UV filters.
  • the combination tion of at least one water-insoluble UV filter with at least one UV filter with a cationic group preferred.
  • the UV filters (I) are contained in the compositions according to the invention usually in amounts of 0.1-5 wt .-%, based on the total agent. Levels of 0.4-2.5 wt .-% are preferred.
  • the action of the active ingredient complex (A) according to the invention can furthermore be increased by a 2-pyrrolidinone-5-carboxylic acid and its derivatives (J).
  • Another object of the invention is therefore the use of the active ingredient in combination with derivatives of 2-pyrrolidinone-5-carboxylic acid.
  • the sodium, potassium, calcium, magnesium or ammonium salts in which the ammonium ion in addition to hydrogen carries a 4 alkyl groups or three Ci to C are preferred.
  • the sodium salt is most preferred.
  • the amounts used in the inventive compositions are 0.05 to 10 wt.%, Based on the total agent, particularly preferably 0.1 to 5, and in particular 0.1 to 3 wt.%.
  • penetration aids and / or swelling agents include, for example, urea and urea derivatives, guanidine and its derivatives, arginine and its derivatives, water glass, imidazole and its derivatives, histidine and its derivatives, benzyl alcohol, glycerol, glycol and glycol ethers, propylene glycol and propylene glycol ethers, for example propylene glycol monoethyl ether, carbonates, bicarbonates, Diols and triols, and especially 1,2-diols and 1,3-diols such as 1,2-propanediol, 1, 2-pentanediol, 1,2-hexanediol, 1, 2-dodecanediol, 1,3-propanediol, 1 , 6-hexanediol, 1,5-pentanedi
  • polyhydroxy compounds not only affect the body cleansing compositions of the present invention Moisture, but they also lead to a much better processability of the pieces masses for the production of shaped body cleansing pieces.
  • At least one polyhydroxy compound having at least 2 OH groups is contained.
  • these compounds those having 2 to 12 OH groups, and especially those having 2, 3, 4, 5, 6 or 10 OH groups are preferred.
  • polyhydroxy compounds (C) are understood as meaning all substances which fulfill the definition in Rompp's Lexikon der Chemie, Version 2.0 of the CD-ROM edition of 1999, Verlag Georg Thieme. Accordingly, polyhydroxy compounds are understood as meaning organic compounds having at least two hydroxyl groups. In particular, for the purposes of the present invention, this is to be understood as meaning:
  • Polyols having at least two hydroxyl groups such as trimethylolpropane, carbohydrates, sugar alcohols and sugars and salts thereof, in particular monosaccharides, disaccharides, trisaccharides and oligosaccharides, these also in the form of aldoses, ketoses and / or lactoses, and protected by conventional and in the literature known -OH and -NH - protecting groups, such as the triflate group, the trimethylsilyl group or acyl groups and also in the form of the methyl ethers and as phosphate esters may be present, aminodeoxysugars, deoxysugars, thioxides, these also in the form of aldoses, ketoses and / or Lactoses, as well as protected by conventional and known in the literature -OH and -NH - protecting groups, such as the triflate, the trimethylsilyl or acyl groups, and furthermore in the form of methyl ethers and as a phosphate ester may be present,
  • monosaccharides having 3 to 8 C atoms such as, for example, trioses, tetroses, pentoses, hexoses, heptoses and octoses, these also being protected in the form of aldoses, ketoses and / or lactoses and by conventional and known in the literature -OH and -NH - protecting groups, such as for example the triflate group, the trimethylsilyl group or acyl groups and furthermore in the form of the methyl ethers and as phosphate esters,
  • oligosaccharides having up to 50 monomer units, these also being protected in the form of aldoses, ketoses and / or lactoses and protected by customary and known in the literature -OH and -NH protective groups, such as, for example, the triflate group, the trimethylsilyl group or acyl groups, and furthermore in the form of the methyl ethers and as phosphate esters.
  • polyols according to the invention examples include sorbitol, inositol, mannitol, tetrite, pentite, hexite, threitol, erythritol, adonite, arabitol, xylitol, dulcitol, erythrose, threose, arabinose, ribose, xylose, lyxose, glucose, galactose, mannose, allose , Altrose, gulose, idose, talose, fructose, sorbose, psicose, tegatose, deoxyribose, glucosamine, galactosamine, rhamnose, digitoxose, thioglucose, sucrose, lactose, trehalose, maltose, cellobiose, melibiose, gestiobiose, sorb
  • Preferred polyhydroxy compounds are sorbitol, inositol, mannitol, threitol, erythrose, erythrose, threose, arabinose, ribose, xylose, glucose, galactose, mannose, allose, fructose, sorbose, deoxyribose, glucosamine, galactosamine, sucrose, lactose, trehalose, maltose and cellobiose , Particular preference is given to using glucose, galactose, mannose, fructose, deoxyribose, glucosamine, sucrose, lactose, maltose and cellobiose. However, the use of glucose, galactose, mannose, fructose, sucrose, lactose, maltose or cellobiose is very particularly preferred.
  • the teaching of the invention includes all isomeric forms, such as eis - trans - isomers, diastereomers, epimers, anomers and chiral isomers. According to the invention, it is also possible to use a mixture of several active substances (C).
  • 1,3-diols such as H- (CH 2 ), - CH (OH) CH 2 CH 2 OH with n - 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13, 14, 15, 16, 17, 18, 19, 20 can be used according to the invention.
  • the (n, n + l) - or (n, n + 2) -diols with non-terminal OH groups can also be used.
  • polyhydroxy compounds having 2 OH groups are also the polyethylene and polypropylene glycols.
  • glycerin is of outstanding importance.
  • compositions of the present invention wherein the polyhydroxy compound is selected from ethylene glycol, propylene glycol, polyethylene glycol, polypropylene glycol, glycerin, glucose, fructose, pentaerythritol, sorbitol, mannitol, xylitol and their mixtures may be preferred.
  • agents according to the invention are preferred which, based on the weight of the composition, comprise 0.01 to 20% by weight, preferably 0.01 to 10% by weight, particularly preferably 0.05 to 7.5% by weight and in particular 0.1 to 5.0% by weight of polyhydroxy compound (s).
  • the active compounds (C) according to the invention are present in the compositions in concentrations of from 0.01% by weight to 20% by weight, preferably from 0.01% by weight up to 15% by weight and very particularly preferably in amounts of 0.1 % By weight up to 10% by weight.
  • the agents according to the invention may additionally comprise polyethylene glycol ethers of the formula (IV)
  • k is a number between 1 and 18, with particular preference given to the values 0, 10, 12, 16 and 18 and n is a number between 2 and 20 with particular preference given to the values 2, 4, 5, 6, 7, 8, 9 , 10, 12 and 14 means.
  • Preferred among these are the alkyl derivatives of diethylene glycol, triethylene glycol, tetraethylene glycol, pentahylene glycol, hexaethylene glycol, heptaethylene glycol, octaethylene glycol, nonaethylene glycol, decaethylene glycol, dodecaethylene glycol and tetradecaethylene glycol, and the alkyl derivatives of dipropylene glycol, tripropylene glycol, tetrapropylene glycol, of pentapropylene glycol, hexapropylene glycol, heptapropylene glycol, octapropylene glycol, nonapropylene glycol, decapropylene glycol, dodecapropylene glycol and tetradecaprop
  • mixtures of "short chain” polyalkylene glycol ethers with such "long chain” polyalkylene glycol ethers have advantages. Particular preference is given to mixtures of polyalkylene glycol ethers having a degree of oligomerization of 5 or less with polyalkylene glycol ethers having a degree of oligomerization of 7 or more Preferred mixtures of alkyl derivatives of diethylene glycol, Triethylene glycol, tetraethylene glycol, pentahydylene glycol, dipropylene glycol, tripropylene glycol, tetrapropylene glycol or pentapropylene glycol with alkyl derivatives of hexaethylene glycol, heptaethylene glycol, octaethylene glycol, nonaethylene glycol, decaethylene glycol, dodecaethylene glycol, hexapropylene glycol, heptapropylene glycol, octapropylene glycol, Nonapropylene glyco
  • Particularly preferred agents according to the invention are characterized in that they contain at least one polyalkylene glycol ether (IV a) of the formula (IV) in which n is the number 2, 3, 4 or 5 and at least one polyalkylene glycol ether (IV b) of the formula (IV) in which n represents the numbers 10, 12, 14 or 16, wherein the weight ratio (IV b) to (IV a) 10: 1 to 1:10, preferably 7.5: 1 to 1: 5 and in particular 5 : 1 to 1: 1.
  • Very particularly suitable and preferred polyalkylene glycol ethers have an average molecular weight in the range between 2000 and 50,000 daltons.
  • Short-chain carboxylic acids (N) are used in the active ingredient complex (A) with the bead powders.
  • a composition (Al) according to the invention contains a pearl powder, and a further composition (A2) which contains short-chain carboxylic acid.
  • both compositions are packaged and stored independently and combined only immediately prior to use to the active composition (A).
  • the two separate compositions (A1 and A2) can be packed in a two-component package and / or in two double sachets and / or in two portioned bottles, etc.
  • the two separate compositions (Al and A2) can then in turn be combined in a common outer packaging as a kit. The person skilled in the art knows numerous possibilities for this.
  • Short-chain carboxylic acids and their derivatives in the context of the invention are understood to mean carboxylic acids which may be saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic and have a molecular weight of less than 750.
  • carboxylic acids which may be saturated or unsaturated and / or straight-chain or branched or cyclic and / or aromatic and / or heterocyclic and have a molecular weight of less than 750.
  • preference may be given to saturated or unsaturated straight-chain or branched carboxylic acids having a Chain length of 1 to 16 carbon atoms in the chain, most particularly those are those with a chain length of 1 to 12 C - atoms in the chain.
  • the short-chain carboxylic acids according to the invention may have one, two, three or more carboxy groups.
  • Preferred within the meaning of the invention are carboxylic acids having a plurality of carboxy groups, in particular di- and tricarboxylic acids.
  • the carboxy groups may be wholly or partly present as esters, acid anhydride, lactone, amide, imidic acid, lactam, lactim, dicarboximide, carbohydrazide, hydrazone, hydroxam, hydroxime, amidine, amido-dim, nitrile, phosphonic or phosphate ester.
  • the carboxylic acids according to the invention may of course be substituted along the carbon chain or the ring skeleton.
  • the substituents of the carboxylic acids according to the invention include, for example, C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl, aryl, aralkyl and aralkenyl, hydroxymethyl, C 2 -C 8 -hydroxyalkyl, C 2 -C 8 -hydroxyalkenyl, Aminomethyl, C 2 -C 8 -aminoalkyl, cyano, formyl, oxo, thioxo, hydroxy, mercapto, amino, carboxy or imino groups.
  • Preferred substituents are C 1 -C 8 alkyl, hydroxymethyl, hydroxy, amino and carboxy groups. Particularly preferred are substituents in ⁇ - position.
  • substituents are hydroxyl, alkoxy and amino groups, where the amino function may optionally be further substituted by alkyl, aryl, aralkyl and / or alkenyl radicals.
  • preferred carboxylic acid derivatives are the phosphonic and phosphate esters.
  • carboxylic acids examples include formic acid, acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, pivalic acid, oxalic acid, malonic acid, succinic acid, glutaric acid, glyceric acid, glyoxylic acid, adipic acid, pimelic acid, suberic acid, azelaic acid, sebacic acid, propiolic acid, croton acid, isocrotonic acid, elaidic acid, maleic acid, fumaric acid, muconic acid, citraconic acid, mesaconic acid, camphoric acid, benzoic acid, o, m, p-phthalic acid, naphthoic acid, toluoic acid, hydratropic acid, atropic acid, cinnamic acid, isonicotinic acid, nicotinic acid, bicarbamic acid, 4,4'- Dicyano-6,
  • Carbamoyloctanoic acid 1, 2,4-pentanetricarboxylic acid, 2-pyrrolecarboxylic acid, 1, 2,4,6,7-naphthalenepentaacetic acid, malonaldehyde acid, 4-hydroxy-phthalamic acid, 1- Pyrazolecarboxylic acid, gallic acid or propane tricarboxylic acid, a dicarboxylic acid selected from the group formed by compounds of general formula (NI),
  • n is a number from 4 to 12 and one of the two groups X and Y is a COOH group and the other is hydrogen or a methyl or Ethyl radical
  • dicarboxylic acids of the general formula (NI) which additionally carry 1 to 3 methyl or ethyl substituents on the cyclohexene ring and dicarboxylic acids formed formally from the dicarboxylic acids according to formula (NI) by addition of a molecule of water to the double bond in the cyclohexene ring.
  • German Patent 22 50 055 discloses the use of these dicarboxylic acids in liquid soap masses.
  • German Offenlegungsschrift 28 33 291 discloses deodorizing agents which contain zinc or magnesium salts of these dicarboxylic acids.
  • German Patent Application 35 03 618 means for washing and rinsing the hair are known in which by adding these dicarboxylic acids a noticeably improved hair cosmetic effect of the water-soluble ionic polymers contained in the means is obtained.
  • German Patent Application 197 54 053 means for hair treatment are known which have nourishing effects.
  • the dicarboxylic acids of the formula (NI) can be prepared, for example, by reacting polyunsaturated dicarboxylic acids with unsaturated monocarboxylic acids in the form of a Diels-Alder cyclization.
  • a polyunsaturated fatty acid as the dicarboxylic acid component.
  • Preferred is the linoleic acid obtainable from natural fats and oils.
  • Acrylic acid but also, for example, methacrylic acid and crotonic acid are particularly preferred as the monocarboxylic acid component.
  • mixtures of isomers are formed in which one component is present in excess. These isomer mixtures can be used according to the invention as well as the pure compounds.
  • the dicarboxylic acid (mixture), which is obtained by reacting linoleic acid with acrylic acid, has proved to be particularly effective according to the invention. It is a mixture of 5- and 6-carboxy-4-hexyl-2-cyclohexene-1-octanoic acid.
  • Such compounds are commercially available under the designations Westvaco Diacid 1550 Westvaco Diacid 1595 ® (manufacturer: Westvaco).
  • carboxylic acids of the invention listed above by way of example, their physiologically tolerable salts can also be used according to the invention.
  • examples of such salts are the alkali metal salts, alkaline earth metal salts, zinc salts and ammonium salts, which in the context of the present application also includes the mono-, di- and trimethyl-, -ethyl- and -hydroxyethyl ammonium salts.
  • neutralized acids can very particularly preferably be used with alkaline-reacting amino acids, such as, for example, arginine, lysine, ornithine and histidine. It can continue for formulation reasons, it is preferable to select the carboxylic acid from the water-soluble representatives, in particular the water-soluble salts.
  • the very particularly preferred short-chain carboxylic acids according to the invention include the hydroxycarboxylic acids and here again in particular the dihydroxy, trihydroxy and polyhydroxycarboxylic acids and the dihydroxy, trihydroxy and polyhydroxy di-, tri- and polycarboxylic acids.
  • hydroxycarboxylic acids examples include glycolic acid, glyceric acid, lactic acid, malic acid, tartaric acid or citric acid.
  • these acids are used in the form of mixed salts, for example with amino acids. This may be preferred according to the invention.
  • hydroxycarboxylic acid esters are, for example, full esters of glyceric acid, glycolic acid, lactic acid, malic acid, tartaric acid or citric acid.
  • suitable hydroxycarboxylic acid esters are esters of ⁇ -hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid.
  • esters are primary, linear or branched aliphatic alcohols having 8 to 22 carbon atoms, ie, for.
  • fatty alcohols or synthetic fatty alcohols are particularly preferred.
  • Esters of this type are commercially available, e.g. B. under the trademark Cosmacol ® the EniChem, Augusta Industriale.
  • Particularly preferred polyhydroxypolycarboxylic acids are polylactic acid and polyuric acid and their esters.
  • the teaching of the invention includes all isomeric forms, such as eis - trans - isomers, diastereomers and chiral isomers. According to the invention it is also possible to use a mixture of several short-chain carboxylic acids.
  • the short-chain carboxylic acids according to the invention are present in the compositions in concentrations of 0.01% by weight up to 20% by weight, preferably from 0.05% by weight up to 15% by weight and very particularly preferably in amounts of 0.1% by weight. % up to 5% by weight.
  • Perfumes and / or perfume oils are used in the compositions of the invention to provide the consumer with a corresponding fragrance experience. Of course, it also covers unwanted scents from the individual raw materials.
  • perfume means perfume oils, fragrances and fragrances. As perfume oils are called mixtures of natural and synthetic fragrances.
  • Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (aniseed, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (macis, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme, chamomile ), Needles and twigs (spruce, fir, pine, pines), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • animal raw materials come into question, such as civet and Castoreum.
  • Typical synthetic fragrance compounds are ester type products, ethers, aldehydes, ketones, alcohols and hydrocarbons.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, Cyclohexyl salicylate, Floramat, Melusat, Jasmecyclat and Benzylsalicylat.
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones such as the ionone, oc-isomethylionone and Methylcedrylketon
  • the alcohols include anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol;
  • the hydrocarbons mainly include terpenes and balsams such as limonene and pinene.
  • fragrance oils which are most commonly used as aroma components, are useful as perfume oils, e.g. Sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • fragrances which may be present in the compositions according to the invention are found, for example, in US Pat. In S. Arctander, Perfume and Flavor Materials, Vol. I and II, Montclair, NJ, 1969, Dverlag or K. Bauer, D. Garbe and H. Surburg, Common Fragrance and Flavor Materials, 3 rd . Ed., Wiley-VCH, Weinheim 1997.
  • a fragrance In order to be perceptible, a fragrance must be volatile, with molecular weight also playing an important role in addition to the nature of the functional groups and the structure of the chemical compound. So most perfumes have molecular weights up to about 200 Dalton, while molar masses of 300 daltons and above are more of an exception. Due to the different volatility of fragrances, the odor of a perfume or fragrance composed of several fragrances changes during evaporation, whereby the odor impressions in "top note”, “middle note or body” as well as " Since odor perception is also largely based on the odor intensity, the top note of a perfume does not consist solely of volatile compounds, while the base note consists for the most part of less volatile, ie adherent fragrances.
  • Adhesive-resistant fragrances which are advantageously usable in the context of the present invention are, for example, the essential oils such as angelica root oil, aniseed oil, Arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl, Edeltannenzapfenapfen, Elemiöl, eucalyptus oil, fennel oil, spruce oil, galbanum oil, geranium oil, gingergrass oil , Guajac Wood Oil, Gurjun Balm Oil, Helichrysum Oil, Ho Oil, Ginger Oil, Iris Oil, Cajeput Oil, Calam Oil, Chamomile Oil, Camphor Oil, Kanaga Oil, Cardamom Oil, Cassia Oil, Pine Needle Oil, Kopa ⁇ vaba Balsam Oil, Coriander Oil,
  • the essential oils such as angelica root oil, aniseed oil, Arnica blossom oil, basil oil, bay oil, bergamot oil, Champacablütenöl, Edeltannenöl,
  • Rose oil rosemary oil, sandalwood oil, celery oil, spiked oil, star aniseed oil, turpentine oil, thuja oil, thyme oil, verbena oil, vetiver oil, juniper berry oil, wormwood oil, wintergreen oil, ylang ylang oil, hyssop oil, cinnamon oil, cinnamon oil, citron oil, lemon oil and cypress oil.
  • fragrances can be used in the context of the present invention advantageously as adherent fragrances or fragrance mixtures, ie fragrances.
  • These compounds include the following compounds and mixtures thereof: ambrettolide, amyl cinnamic aldehyde, anethole, anisaldehyde, anisalcohol, anisole, methyl anthranilate, acetophenone, benzylacetone, benzaldehyde, Ethyl benzoate, benzophenone, benzyl alcohol, benzyl acetate, benzyl benzoate, benzyl formate, benzyl valerate, borneol, bornyl acetate, bromostyrene, n-decyl aldehyde, n-dodecyl aldehyde, eugenol, eugenol methyl ether, eucalyptol, farnesol
  • Hydroxycinnamaldehyde hydroxycinnamyl alcohol, indole, iron, isoeugenol, isoeugenol methyl ether, isosafrole, jasmon, camphor, karvakrol, karvon, p-cresol methyl ether, coumarin, p-methoxyacetophenone, methyl n-amyl ketone, methyl anthranilate, p-methylacetophenone, methylchavikole, p-methylquinoline, Methyl naphthyl ketone, methyl n-nonyl acetaldehyde, methyl n-nonyl ketone, muscone, naphthol ethyl ether, naphthol methyl ether, nerol, nitrobenzene, n-nonyl aldehyde, nonyl alcohol, n-octyl aldehyde, p-oxy
  • Salicylic acid cyclohexyl esters, santalol, skatole, te ⁇ ineol, thymes, thymol, undelactone, vaniline, veratrum aldehyde, cinnamaldehyde, cimat alcohol, cinnamic acid, cinnamic acid ethyl ester, cinnamic acid benzyl ester.
  • the lower-boiling fragrances include natural or synthetic origin, which can be used alone or in mixtures.
  • Examples of more readily volatile fragrances are alkyl isothiocyanates (alkyl mustard oils), butanedione, limonene, linalool, linayl acetate and propionate, menthol, menthone, methyl-n-heptenone, phellandrene, phenylacetaldehyde, terpinyl acetate, citral, citronellal.
  • fragrances can be used alone or in a mixture according to the present invention with the advantages already mentioned. If the boiling points of the individual fragrances are substantially below 300 ° C., then a preferred embodiment of the invention is present, wherein preferably at least 50% of the fragrances contained have a boiling point below 300 ° C., advantageously at least 60%, more preferably at least 70%. , in an even more advantageous manner at least 80%, in an extremely advantageous manner at least 90%, in particular even 100%.
  • Boiling points below 300 ° C are therefore advantageous because the fragrances would have too low a volatility at higher boiling points.
  • a certain volatility of the fragrances is advantageous.
  • Unstable fragrances for the purposes of this invention can be identified by incorporating a perfume composition comprising at least 6 fragrances into activated / dehydrated zeolite X and storing the resulting sample for 24 hours at room temperature. Then the fragrances are extracted with acetone and analyzed by gas chromatography to determine the stability.
  • a fragrance is considered to be unstable in the context of this invention, if at least 50 wt .-%, preferably at least 65 wt .-%, advantageously at least 80 wt .-%, in particular at least 95 wt .-% of this perfume decomposed into degradation products, and in the extraction can not be provided again.
  • the inventive composition less than 15 wt .-%, preferably less than 8 wt .-%, advantageously less than 6 wt .-%, more preferably less than 3 Wt .-%, of unstable perfume, based on the total amount of perfume ad / absorbed in / on the particle, so there is a preferred embodiment of the invention, wherein the unstable perfume in particular the group of allyl alcohol esters, esters of secondary alcohols Esters of tertiary alcohols, allylic ketones, condensation products of amines and aldehydes, acetals, ketals and mixtures of the foregoing.
  • the unstable perfume in particular the group of allyl alcohol esters, esters of secondary alcohols Esters of tertiary alcohols, allylic ketones, condensation products of amines and aldehydes, acetals, ketals and mixtures of the foregoing.
  • perfume adsorbed in / on the particle ad / at least 4 advantageously at least 5, in a further advantageous manner at least 6, more preferably at least 7, even more preferably at least 8, preferably at least 9, in particular at least Contains 10 different fragrances, so is a preferred embodiment of the invention.
  • the logP value of the perfume components adsorbed in / on the particle ad / is substantially at least 2, preferably at least 3 or greater, so that at least 40%, advantageously at least 50%, more preferably at least 60%, more preferably at least 70%, preferably at least 80%, in particular 90% of the perfume components fulfill this log requirement, then a preferred embodiment of the invention is present.
  • the logP value is a measure of the hydrophobicity of the perfume components. It is the decadic logarithm of the partition coefficient between n-octanol and water.
  • the octanol / water partition coefficient of a perfume ingredient is the ratio between its equilibrium concentrations in water and octanol.
  • a perfume ingredient with higher partition coefficient P is more hydrophobic.
  • the stated conditions for the logP are advantageous because it ensures that the fragrances can be better retained in the pores of the support material and also better on objects which are treated with the particles (for example, indirectly by treatment with a detergent formulation, those who containing particles according to the invention) precipitate.
  • the logP value of many perfume ingredients is given in the literature; For example, the Pomona 92 database, available from Daylight Chemical Information Systems, Inc. (Daylog CIS) of Irvine, California, contains many such values along with references to the original literature.
  • the logP values can also be calculated, for example, with the "CLOG P" program of the aforementioned company Daylight CIS.
  • ClogP values Values should also include the Clog-P values
  • Clog-P values should then be used for hydrophobicity estimation if there are no experimental logP values for certain perfume constituents.
  • the perfume can also be combined with a perfume fixative. It is believed that perfume fixatives can slow the exhalation of higher volatile fractions of perfume.
  • the perfume which is adsorbed in / on the carrier material comprises a perfume fixative, preferably in the form of diethyl phthalates, musk (derivatives) and mixtures thereof, the fixative amount preferably being from 1 to 55% by weight. , Advantageously, 2 to 50 wt .-%, more preferably 10 to 45 wt .-%, in particular 20 to 40 wt .-% of the total amount of perfume.
  • the particles contain a viscosity of liquids, in particular perfume-increasing agent, preferably PEG (polyethylene glycol), advantageously having a molecular weight of 400 to 2000, wherein the viscosity increasing agent in a preferred manner in amounts of 0.1 to 20 wt .-%, advantageously from 0.15 to 10 wt .-%, more preferably from 0.2 to 5 wt .-%, in particular from 0.25 to 3 wt .-% is contained, based on the particles.
  • PEG polyethylene glycol
  • the viscosity-increasing agents are preferably polyethylene glycols (PEG for short) which can be described by the general formula I:
  • n of about 5 to> 100,000 corresponding to molecular weights of 200 to 5,000,000 gmol-1, may vary.
  • the products with molecular weights below 25,000 g / mol are referred to as actual polyethylene glycols, while higher molecular weight products are often referred to in the literature as polyethylene oxides (PEOX for short).
  • the polyethylene glycols preferably used may have a linear or branched structure, with particular preference being given to linear polyethylene glycols and end-capped.
  • the particularly preferred polyethylene glycols include those having molecular weights between 400 and 2000. It can be used in particular also polyethylene glycols, which are present in a liquid state at room temperature and a pressure of 1 bar; Here is mainly of polyethylene glycol with a molecular weight of 200, 400 and 600 the speech.
  • the perfumes are generally added in an amount of 0.05 to 5 wt .-%, preferably from 0.1 to 2.5 wt .-%, particularly preferably from 0.2 to 1.5 wt .-%, based on the total composition, of the total composition.
  • the perfumes may be added to the compositions in liquid form, neat or diluted with a solvent for perfuming. Suitable solvents for this purpose are, for. For example, ethanol, isopropanol, diethylene glycol monoethyl ether, glycerol, propylene glycol, 1,2-butylene glycol, dipropylene glycol, diethyl phthalate, triethyl citrate, isopropyl myristate, etc.
  • the perfumes for the compositions of the invention may be adsorbed to a carrier which provides both a fine distribution of the fragrances in the product and a controlled release in use.
  • a carrier which provides both a fine distribution of the fragrances in the product and a controlled release in use.
  • Such carriers can be porous inorganic materials such as light sulfate, silica gels, zeolites, gypsum, clays, clay granules, aerated concrete, etc., or organic materials such as woods and cellulosic based materials.
  • perfume oils for the compositions according to the invention can also be microencapsulated, spray-dried, present as inclusion complexes or as extrusion products and added in this form to the compositions to be perfumed.
  • the properties of the perfume oils modified in this way can be further optimized by so-called “coating” with suitable materials with a view to a more targeted release of fragrance, for which purpose preferably wax-like plastics, such as, for example, As polyvinyl alcohol can be used.
  • suitable materials such as, for example, As polyvinyl alcohol can be used.
  • the consumer in the perception of the cosmetic compositions, in particular caused by a aesthetically appealing packaging, optionally in conjunction with aromatic fragrances, may associate the composition of the invention with a stimulant such as confectionery or beverages.
  • a stimulant such as confectionery or beverages.
  • oral ingestion or swallowing of the cosmetic composition can not be ruled out in principle.
  • contain the compositions according to the invention have a bittering agent to prevent swallowing or accidental ingestion.
  • bitter substances are erf ⁇ ndungswash preferred which are soluble in water at l 20 0 C of at least 5 g / cc.
  • the ionogenic bitter substances have proved superior to the nonionic ones.
  • Ionogenic bitter substances preferably consisting of organic cation (s) and organic anion (s), are therefore preferred for the preparations according to the invention.
  • Quaternary ammonium compounds which contain an aromatic group both in the cation and in the anion are outstandingly suitable as bitter substances.
  • One such compound is commercially available for example under the trademark Bitrex ® and with indigenous stin ® available benzyldiethyl ((2,6-Xylylcarbamoyl) methyl) ammonium benzoate. This compound is also known by the name Denatonium Benzoate.
  • the bitter substance is present in the moldings according to the invention in amounts of from 0.0005 to 0.1% by weight, based on the molding. Particular preference is given to amounts of from 0.001 to 0.05% by weight.
  • dyes the substances suitable and suitable for cosmetic purposes can be used, as compiled, for example, in the publication "Cosmetic Colorants” of the Dye Commission of the Irish Klastician, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1 wt .-%, based on the total mixture.
  • any acid or base that can be used for cosmetic purposes can be used.
  • the use of the active ingredient combination according to the invention is also for adjusting the pH particularly preferred.
  • Preferred bases are ammonia, alkali hydroxides, monoethanolamine, triethanolamine and N, N, N ', N'-tetrakis (2-hydroxypropyl) ethylenediamine.
  • acids are used as acids.
  • By-acids are understood to mean those acids which are absorbed as part of the usual food intake and have positive effects on the human organism.
  • Eat acids are, for example, acetic acid, lactic acid, tartaric acid, citric acid, malic acid, ascorbic acid and gluconic acid.
  • citric acid and lactic acid is particularly preferred.
  • the active substance complex (A) according to the invention can in principle be added directly to the colorant, the corrugating agent or the fixation.
  • the application of the active substance complex to the keratinic fiber can also take place in a separate step, either before or after the actual dyeing or corrugating process.
  • Separate treatments, optionally also days or weeks before or after the hair treatment, for example by dyeing or waves, are encompassed by the teaching according to the invention.
  • the application of the active substance complex according to the invention after the corresponding hair treatment such as dyeing or waves can be carried out in particular in the corresponding hair treatment compositions.
  • dyeing process comprises all processes known to those skilled in the art, in which a colorant is applied to the hair, which may have been moistened, and left on the hair either for a period of a few minutes to about 45 minutes and then with water or a surfactant-containing agent is rinsed or left completely on the hair. It is in this context explicitly on the known monographs, z. BKH Schrader, bases and formulations of cosmetics, 2nd edition, Wegig book publishing house, Heidelberg, 1989, referenced, which reflect the corresponding knowledge of the professional.
  • corrugating process encompasses all processes known to those skilled in the art in which a corrugating agent is applied to the hair, which may have been moistened and wound on winder, and left on the hair either for a period of a few minutes to about 45 minutes and then with water or a surfactant-containing agent is rinsed out, then a permanent wave fixation is applied to the hair and this left for a time between a few minutes and about 45 minutes on the hair and then rinsed with water or a surfactant-containing agent. It is in this context explicitly on the known monographs, z. BKH Schrader, bases and formulations of cosmetics, 2nd edition, Hüthig book publishing house, Heidelberg, 1989, referenced, which reflect the corresponding knowledge of the professional.
  • the active ingredient complex according to the invention is applied to the keratinic fiber, in particular human hair
  • emulsions such as W / O, O / W
  • PIT emulsions known as phase inversion emulsions, PIT
  • microemulsions and multiple emulsions gels, Sprays, aerosols and foam aerosols suitable.
  • the pH of these preparations can in principle be between 2 and 11. It is preferably between 2 and 9, values of 2 to 7 being particularly preferred.
  • any acid or base that can be used for cosmetic purposes can be used.
  • Preferred bases are ammonia, alkali hydroxides, monoethanolamine, triethanolamine and N, N, N ', N'-tetrakis (2-hydroxypropyl) ethylenediamine.
  • hair-remaining preparations are understood as meaning those preparations which are not released from the hair within the scope of the treatment after a period of a few seconds to one hour with the aid of water or an aqueous solution. be rinsed. Rather, the preparations remain on the hair until the next hair wash, ie usually more than 12 hours.
  • these preparations are formulated as hair conditioners or hair conditioners.
  • the preparations according to the invention according to this embodiment can be rinsed off after expiry of the contact time with water or an agent which is at least predominantly hydrous; however, they may be left on the hair as stated above. It may be preferred to apply the preparation according to the invention to the hair before the application of a cleansing agent, a waving agent or other hair treatment agents. In this case, the preparation according to the invention serves as a structural protection for the following applications.
  • the agents according to the invention may also be, for example, cleansing agents such as shampoos, nourishing agents such as rinses, firming agents such as hair setting agents, mousses, styling gels and hair drier, permanent shaping agents such as perming and fixing agents and especially within the framework of a perming method or dyeing process used pre-treatment or rinsing act.
  • cleansing agents such as shampoos
  • nourishing agents such as rinses
  • firming agents such as hair setting agents, mousses, styling gels and hair drier
  • permanent shaping agents such as perming and fixing agents and especially within the framework of a perming method or dyeing process used pre-treatment or rinsing act.
  • All embodiments described above for the application of the agents according to the invention can be both one-component and two-component systems.
  • the embodiment is preferably as a two-component system.
  • This base formulation contains essentially all the ingredients of the overall formulation, including the short chain carboxylic acids except the pearl powder.
  • the second component to be mixed into the base formulation essentially contains the pearl powder.
  • any further constituents of the overall formulation may also be contained in the second component, as long as this second component has a pH in the range from 7 to 11 and all ingredients are below these conditions are stable without decomposition.
  • This component has a pH of 7 to 11.
  • the mixing ratio of the two components is 10: 1 to 1:10, preferably 5: 1 to 1: 5, more preferably 2.5: 1 to 1: 2.5, and most preferably 1.25: 1 to 1: 1, 25th
  • the overall composition according to the invention is formulated as a two-component system, it may be necessary to stabilize the pearl powder in the second component so that the pearl powder is homogeneously distributed in the composition and no separations take place, either by settling or floating of the powder. Furthermore, stabilization may be necessary if the pearl powder is used as clearly visible particles.
  • the particle size of the bead powder can be from 0.1 ⁇ m to 5000 ⁇ m. It is according to the invention both preferred to use particles in a range of 0.1 to 30 microns and in a range of 50 to 5000 microns. In the first, small particle size range, the small particle size results in faster dissolution of the bead powder in blending the two components to the overall composition. In the second, larger particle range of the pearl powder, the particle size is in the range of visible to the human eye particles. As a result, an aesthetic overall appearance of the two components for the consumer is achieved.
  • emulsion stabilizing polymers are used to stabilize the component containing the bead powder particles. These are understood to mean polymers which essentially support the structure and the stabilization of emulsions (O / W and W / O as well as multiple emulsions). Surfactants and emulsifiers are of course included as further ingredients, but the stabilizing polymers contribute to a reduction in the coalescence of the emulsified particles by positively affecting the continuous or disperse phase. This positive influence may be due to an electrical repulsion, an increase in viscosity or a film formation on the surface of the droplets.
  • Examples of such polymers are Acrylamide / Sodium Acryloyl Dimethyl Taurate Copolymer, Acrylates / Amino Acrylates / C 10-30 Alkyl PEG-20 Itaconate Copolymer, Acrylates / C 10-30 Alkyl Acrylate Crosspolymer, Acrylates / Stearyl Methacrylate Copolymer, Acrylates / Vinyl Isodecanoate Crosspolymer, Alcaligenes Polysaccharides , Allyl Methacrylate Crosspolymer, Ammonium Acryloyldimethyltaurate / Beheneth-25 Methacrylate Crosspolymer, Ammonium Acryloyldimethyltaurate / Vinyl Formamide Copolymer, Ammonium Alginate, Ammonium Phosphatidyl Rapeseedate, Ammonium Polyacrylate, Ammonium Polyacryloyldimethyl Taurate, Ammonium Shellacate, Arachidyl Alcohol, Astragalus Gummifer
  • emulsion-stabilizing polymers can also be used for the emulsion-stabilizing polymers. Often, both polymers are also identical.
  • Suspension stabilizing polymers are suspending agents. Suspension aids facilitate the distribution of solids in liquids. Here, the polymers occupy the surface of the solid particles by adsorption and thereby change the surface properties of the solids. The following are examples of these polymers:
  • These two polymeric auxiliaries are in an amount of 0.01 to 15 wt.%, Preferably 0.01 to 10 wt.%, Particularly preferably 0.01 to 7.5 wt.% And most preferably 0.01 to 5 wt .% contain.
  • these types of polymers may also be included in the base formulation.
  • compositions according to the invention consist of at least one transparent to clear phase and of at least one non-transparent, non-clear phase.
  • the pearl powder may be contained both in the transparent and in the non-transparent phase.
  • Transparency in the sense of the invention is understood as meaning the permeability of the composition according to the invention to the visible light. To do this, measure the permeability of the composition according to the invention at a layer thickness of 1 cm. This is measured in a conventional measuring device with visible light. From a transmittance of at least 20% of the visible light is spoken of transparency in the context of the present invention.
  • a permeability of at least 60% is spoken clearly within the meaning of the invention.
  • a permeability of at least 40% is preferred according to the invention.
  • a transmittance of at least 60% is particularly preferred, a visible light transmittance of at least 75% is most preferred.
  • a permeability of at least 85% is most preferred.
  • Another embodiment of the present invention consists of a liquid composition and a molding.
  • the liquid composition contains all essential ingredients except the pearl powder.
  • the liquid composition has a pH of 2 to 6.
  • the solid shaped body contains the pearl powder and other aids necessary for the production of shaped bodies.
  • the pearl powder is present as a visible particle in a transparent, liquid to liquid viscous composition.
  • This composition then has a pH of from 7 to 11, preferably from 7 to 9 and very particularly preferably from 7 to 8.
  • the short-chain carboxylic acid is then present as a shaped body.
  • dissolution accelerator includes gas-evolving components, preformed and trapped gases, disintegrants, and mixtures thereof.
  • dissolution accelerator, mold disintegrant, disintegrants or disintegrants are meant substances which are added to tablets to accelerate their disintegration upon contact with water or other solvents. Reviews on this can be found, for example, in J. Pharm. Sei. 6J_ (1972), Römpp Chemilexikon, 9th edition, Volume 6, page 4440 and Voigt "textbook of pharmaceutical technology” (6th edition, 1987, pp. 182-184).
  • gas-evolving components are used as the dissolution accelerator. Upon contact with water, these components react with each other to form gases in-situ, which create a pressure in the tablet which disintegrates the tablet into smaller particles.
  • suitable acids Preference is given to mono-, di- or trihydric acids having a pK a value of 1.0 to 6.9.
  • Preferred acids are citric, malic, maleic, malonic, itaconic, tartaric, oxalic, glutaric, glutamic, lactic, fumaric, glycolic and mixtures thereof. Particularly preferred is citric acid.
  • citric acid in particulate form, the particles having a diameter of below 100 ⁇ m, in particular smaller than 700 ⁇ m, very particularly preferably smaller than 400 ⁇ m.
  • suitable acids are the homopolymers or copolymers of acrylic acid, maleic acid, methacrylic acid or itaconic acid having a molecular weight of 2,000 to 200,000. Particularly preferred are homopolymers of acrylic acid and copolymers of acrylic acid and maleic acid.
  • preferred bases are alkali metal silicates, carbonates, bicarbonates and mixtures thereof. Metasilicates, bicarbonates and carbonates are particularly preferred, bicarbonates are most preferred.
  • particulate hydrogencarbonates having a particle diameter of less than 100 ⁇ m, in particular less than 700 ⁇ m, very particularly preferably less than 400 ⁇ m.
  • Sodium or potassium salts of the above bases are particularly preferred.
  • These gas-evolving components are contained in the inventive dyeing composition preferably in an amount of at least 10 wt .-%, in particular of at least 20 wt .-%.
  • the gas is preformed or trapped so that upon onset of dissolution of the molded article, gas evolution begins and further dissolution is accelerated.
  • suitable gases are air, carbon dioxide, N 2 O, oxygen and / or other non-toxic, non-combustible gases.
  • disintegration auxiliaries so-called shaped body disintegrants
  • disintegration auxiliaries so-called shaped body disintegrants
  • Swelling disintegration aids are, for example, synthetic polymers such as polyvinylpyrrolidone (PVP) or natural polymers or modified natural substances such as cellulose and starch and their derivatives, alginates or casein derivatives.
  • PVP polyvinylpyrrolidone
  • Preferred disintegrating agents used in the present invention disintegrating agents based on cellulose, so that preferred molded body such disintegrating agent based on cellulose in amounts of 0.5 to 50 wt .-%, preferably 3 to 30 wt .-%, based on the total molding contain.
  • Pure cellulose has the formal gross composition (C 6 Hi 0 Os) n and is formally a ⁇ -l, 4-polyacetal of cellobiose, which in turn is composed of two molecules of glucose.
  • Suitable celluloses consist of about 500 to 5000 Glucose units and therefore have average molecular weights of 50,000 to 500,000.
  • Cellulose-based disintegrating agents which can be used in the context of the present invention are also cellulose derivatives obtainable by polymer-analogous reactions of cellulose.
  • Such chemically modified celluloses include, for example, products of esterifications or etherifications in which hydroxy hydrogen atoms have been substituted.
  • Celluloses in which the hydroxy groups have been replaced by functional groups which are not bonded via an oxygen atom can also be used as cellulose derivatives.
  • the group of cellulose derivatives includes, for example, alkali metal celluloses, carboxymethyl cellulose (CMC), cellulose esters and ethers, and aminocelluloses.
  • the cellulose derivatives mentioned are preferably not used as the sole cellulosic disintegrating agent but are used in admixture with cellulose.
  • the content of these mixtures of cellulose derivatives is preferably below 50% by weight, particularly preferably below 20% by weight, based on the cellulose-based disintegrating agent. It is particularly preferred to use cellulose-based disintegrating agent which is free
  • the cellulose used as disintegration aid can not be used in finely divided form, but converted into a coarser form, for example, granulated or compacted, before admixing with the premixes to be tabletted.
  • the particle sizes of such disintegrating agents are usually above 200 .mu.m, preferably at least 90 wt .-% between 300 and 1600 .mu.m and in particular at least 90 wt .-% between 400 and 1200 microns.
  • the disintegration auxiliaries according to the invention are available commercially for example under the name of Arbocel ® from Rettenmaier.
  • a preferred disintegration assistants for example, Arbocel ® TF-30-HG.
  • microcrystalline cellulose is preferably used as a cellulose-based disintegrant or as a component of this component.
  • This microcrystalline cellulose is obtained by partial hydrolysis of celluloses under conditions which attack only the amorphous regions (about 30% of the total cellulose mass) of the celluloses and completely dissolve, leaving the crystalline areas (about 70%) undamaged. Subsequent deaggregation of the microfine celluloses produced by the hydrolysis yields the microcrystalline celluloses which have primary particle sizes of about 5 ⁇ m and can be compacted, for example, into granules having an average particle size of 200 ⁇ m.
  • Suitable microcrystalline cellulose is available commercially for example under the trade name Avicel ®.
  • disintegrants which may be present within the meaning of the invention, e.g. Kollidon, alginic acid and their alkali metal salts, amorphous or partially crystalline layered silicates (bentonites), polyacrylates, polyethylene glycols are described, for example, in the publications WO 98/40462 (Rettenmaier), WO 98/55583 and WO 98/55590 (Unilever) and WO 98/40463, DE 19709991 and DE 19710254 (Henkel). The teaching of these documents is expressly incorporated by reference.
  • the disintegrants obtainable by the process according to the invention can be present homogeneously distributed macroscopically viewed in the molded body, but microscopically they form zones of increased concentration due to production.
  • the accelerated dissolution of the cosmetic compositions according to the invention present as shaped bodies can also be achieved according to the invention by pre-granulation of the further constituents of the shaped body.
  • compositions according to the invention which are present as shaped bodies, these contain, in addition to the dissolution accelerator, a mixture of starch and at least one saccharide.
  • a mixture of starch and at least one saccharide is preferred.
  • Said mixture is preferably present in a weight ratio of starch and the saccharides used from 10: 1 to 1: 10, more preferably from 1: 1 to 1: 10, most preferably from 1: 4 to 1: 7 in the molding ,
  • the disaccharides used are preferably selected from lactose, maltose, sucrose, trehalose, turanose, gentiobiose, melibiose and cellobiose. Especially Lactose, maltose and sucrose and very particularly preferably lactose are used in the moldings according to the invention.
  • the starch-disaccharide mixture is contained in the shaped body in an amount of 5 to 60% by weight, preferably 20 to 40% by weight, based on the mass of the entire shaped body.
  • compositions according to the invention which are present as moldings may be builders.
  • builders which are useful as optional components are zeolites, water glasses, layered silicates, phosphates and polycarboxylates.
  • the finely crystalline, synthetic and bound water-containing zeolite frequently used as detergent builder is preferably zeolite A and / or P.
  • zeolite P for example, zeolite MAP (R) (commercial product from Crosfield) is particularly preferred.
  • zeolite X and mixtures of A, X and / or P as well as Y.
  • zeolite A and zeolite X which (as VEGOBOND AX ® commercial product of Condea Augusta SpA) is commercially available.
  • the zeolite can be used as a spray-dried powder or else as undried, still moist, stabilized suspension of its preparation.
  • the zeolite may contain minor additions of nonionic surfactants as stabilizers, for example 1 to 3 wt .-%, based on zeolite, of ethoxylated Ci 2 -Ci 8 fatty alcohols with 2 to 5 ethylene - Oxide groups, Ci 2 -C] 4 fatty alcohols with 4 to 5 ethylene oxide groups or ethoxylated isotridecanols.
  • Suitable zeolites have an average particle size of less than 10 ⁇ m (volume distribution, measuring method: Coulter Counter) and preferably contain 18 to 22% by weight, in particular 20 to 22% by weight, of bound water.
  • Suitable substitutes or partial substitutes for phosphates and zeolites are crystalline, layered sodium silicates of the general formula NaMSi x O 2x + TyH 2 O, where M is sodium or hydrogen, x is a number from 1.9 to 4 and y is a number from 0 to 20 is and preferred values for x are 2, 3 or 4.
  • Such crystalline layered silicates are described, for example, in European Patent Application EP 0164514 A1.
  • Preferred crystalline layered silicates of the formula given are those in which M is sodium and x assumes the values 2 or 3.
  • both ⁇ - and ⁇ -sodium disilicates are Na 2 Si 2 (IVyH 2 O preferred, whereby ⁇ -sodium disilicate can be obtained, for example, by the process described in international patent application WO 91/08171
  • ⁇ -sodium disilicate can be obtained, for example, by the process described in international patent application WO 91/08171
  • they are known from the patent applications DE 2334899 A1, EP 0026529 A1 and DE 3526405 A1
  • Their suitability is not limited to a specific composition or structural formula
  • preferred are smectites, especially bentonites
  • Suitable phyllosilicates belonging to the group of water-swellable smectites are, for example, those of the general formulas
  • the phyllosilicates may contain hydrogen, alkali, alkaline earth metal ions, in particular Na + and Ca 2+ , due to their ion-exchanging properties.
  • the amount of water of hydration is usually in the range of 8 to 20 wt .-% and is dependent on the swelling state or on the type of processing.
  • Useful layered silicates are known, for example, from US Pat. No. 3,966,629, US Pat. No. 4,062,647, EP 0026529 A1 and EP 0028432 A1.
  • phyllosilicates are used, which are largely free of calcium ions and strong coloring iron ions due to an alkali treatment.
  • the preferred builder substances also include amorphous sodium silicates with a Na 2 O: SiO 2 modulus of from 1: 2 to 1: 3.3, preferably from 1: 2 to 1: 2.8 and in particular from 1: 2 to 1: 2, 6, which are delay-delayed.
  • amorphous sodium silicates may have been produced in various ways, for example by surface treatment, compounding, compaction / densification or by overdrying.
  • the term "amorphous" is also understood to mean "X-ray amorphous”.
  • the silicates do not give sharp X-ray reflections typical of crystalline substances but at best one or more maxima of the scattered X-rays having a width of several degrees of diffraction angle. However, it may well even lead to particularly good builder properties if the silicate particles provide blurred or even sharp diffraction maxima in electron diffraction experiments. This is to be interpreted as meaning that the products have microcrystalline regions of size 10 to a few hundred nm, values of up to max. 50 nm and in particular up to max. 20 nm are preferred.
  • Such so-called X-ray amorphous silicates which likewise have a dissolution delay compared with the conventional water glasses, are described, for example, in German patent application DE 4400024 A1.
  • Especially preferred are densified / compacted amorphous silicates, compounded amorphous silicates and overdried X-ray amorphous silicates.
  • phosphates As builder substances, if such an application should not be avoided for ecological reasons.
  • Particularly suitable are the sodium salts of orthophosphates, pyrophosphates and in particular tripolyphosphates.
  • Their content is generally not more than 25 wt .-%, preferably not more than 20 wt .-%, each based on the finished agent.
  • tripolyphosphates even in small amounts up to a maximum of 10% by weight, based on the finished agent, in combination with other builder substances lead to a synergistic improvement in the secondary washing power.
  • Useful organic builders which are suitable as co-builders are, for example, the polycarboxylic acids which can be used in the form of their sodium salts, such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids, Aminocarboxylic acids, nitrilotriacetic acid (NTA), if such use is not objectionable for environmental reasons, and mixtures of these.
  • Preferred salts are the salts of polycarboxylic acids such as citric acid, adipic acid, succinic acid, glutaric acid, tartaric acid, sugar acids and mixtures thereof. The acids themselves can also be used.
  • the acids typically also have the property of an acidifying component and thus also serve to set a lower and milder pH of detergents or cleaners.
  • an acidifying component typically also serve to set a lower and milder pH of detergents or cleaners.
  • citric acid, succinic acid, glutaric acid, adipic acid, gluconic acid and any desired mixtures of these can be mentioned here.
  • dextrins for example oligomers or polymers of carbohydrates, which can be obtained by partial hydrolysis of starches.
  • the hydrolysis can be carried out by customary, for example acid or enzyme catalyzed processes. Preference is given to hydrolysis products having average molecular weights in the range from 400 to 500,000.
  • a polysaccharide with a dextrose equivalent (DE) in the range from 0.5 to 40, in particular from 2 to 30 is preferred, DE being a customary measure for the reducing effect of a polysaccharide compared to dextrose, which has a DE of 100.
  • DE dextrose equivalent
  • maltodextrins having a DE of between 3 and 20 and dry glucose syrups having a DE of between 20 and 37 and so-called yellow dextrins and white dextrins having relatively high molecular weights in the range of 2,000 to 30,000.
  • a preferred dextrin is described in British patent application GB 9419091 A1 , The oxidized derivatives of such dextrins are their reaction products with oxidizing agents which are capable of oxidizing at least one alcohol function of the saccharide ring to the carboxylic acid function.
  • Suitable co-builders are oxydisuccinates and other derivatives of disuccinates, preferably ethylenediamine disuccinate. Also particularly preferred in this connection are glyceryl disuccinates and glycerol trisuccinates, as described, for example, in US Pat. Nos. 4,524,009, 4,639,325, European Patent Application EP 0150930 A1 and Japanese Patent Application JP 93/339896. Suitable amounts are in zeolith lotteryn and / or silicate-containing formulations at 3 to 15 wt .-%.
  • organic cobuilders are, for example, acetylated hydroxycarboxylic acids or their salts, which may optionally also be present in lactone form and which contain at least 4 carbon atoms and at least one hydroxyl group and a maximum of two acid groups.
  • Such co-builders are described, for example, in International Patent Application WO 95/20029.
  • Suitable polymeric polycarboxylates are, for example, the sodium salts of polyacrylic acid or polymethacrylic acid, for example those having a relative molecular weight of 800 to 150,000 (based on acid and measured in each case against polystyrenesulfonic acid).
  • Suitable copolymeric polycarboxylates are in particular those of acrylic acid with methacrylic acid and of acrylic acid or methacrylic acid with maleic acid. Copolymers of acrylic acid with maleic acid which contain 50 to 90% by weight of acrylic acid and 50 to 10% by weight of maleic acid have proven to be particularly suitable.
  • Their molecular weight relative to free acids is generally from 5,000 to 200,000, preferably from 10,000 to 120,000 and in particular from 50,000 to 100,000 (in each case measured against polystyrene sulfonic acid).
  • the (co) polymeric polycarboxylates can be used either as a powder or as an aqueous solution, with 20 to 55% by weight aqueous solutions being preferred.
  • Granular polymers are usually added later to one or more basic granules.
  • biodegradable polymers of more than two different monomer units for example those described in DE 4300772 A1 as Monomeric salts of acrylic acid and maleic acid and vinyl alcohol or vinyl alcohol derivatives or according to DE 4221381 C2 as monomers, salts of acrylic acid and 2-alkylallylsulfonic acid and sugar derivatives.
  • Further preferred copolymers are those which are described in German patent applications DE 4303320 A1 and DE 4417734 A1 and preferably have as monomers acrolein and acrylic acid / acrylic acid salts or acrolein and vinyl acetate.
  • polymeric aminodicarboxylic acids, their salts or their precursors Particular preference is given to polyaspartic acids or their salts and derivatives.
  • polyacetals which can be obtained by reacting dialdehydes with polyolcarboxylic acids which have 5 to 7 C atoms and at least 3 hydroxyl groups, for example as described in European patent application EP 0280223 A1.
  • Preferred polyacetals are obtained from dialdehydes such as glyoxal, glutaraldehyde, terephthalaldehyde and mixtures thereof and from polyol carboxylic acids such as gluconic acid and / or glucoheptonic acid.
  • zeolites As builders, they may further contain finely divided, water-insoluble alkali aluminum silicates, with the use of synthetic, bound water-containing crystalline sodium aluminosilicates and especially zeolite A being particularly preferred; Zeolite NaX and its mixtures with zeolite NaA can also be used. Suitable zeolites have a calcium binding capacity in the range of 100 to 200 mg CaO / g. As liquid builders it is also possible to use NTA and / or EDTA.
  • Talc is a hydrated magnesium silicate of the theoretical composition 3MgO 4SiO 2 H 2 O or Mg 3 (Si 4 Oi 0 ) (OH) 2 , which, however, may contain proportions of hydrated magnesium aluminum silicate in an amount having an Al 2 O 3 content of can make up to 12 wt .-%.
  • the particle diameter (equivalent spherical diameter) of the talc should be in the range of 0.5 to 50 ⁇ m. In general, talcum qualities which contain no more than 5% by weight of particles of less than 1 ⁇ m and not more than 5% by weight of particles of more than 50 ⁇ m in size have proved successful.
  • the proportion of particles which are larger than 40 microns in diameter (sieve residue), at most 2 wt .-%, the average particle diameter is preferably from 5 to 15 microns.
  • the content of impurities should not be more than 1.6% by weight of Fe 2 O 3 , 1% by weight of CaO and 1% by weight of unbound water (dry loss at 105 ° C.).
  • the hydrated magnesium aluminosilicate content can be up to 60% by weight (calculated as Al 2 O 3 up to 12% by weight).
  • Suitable finely divided, water-insoluble alkali aluminum silicates are synthetic, bound water-containing, crystalline sodium aluminosilicates, preferably zeolite NaA. Also useful is the zeolite NaX and its mixtures with zeolite NaA. Suitable zeolites have a calcium binding capacity, which is determined according to the information in DE 24 12 837 and which is in the range of 100 to 200 mg CaO / g.
  • the zeolite NaA available with the trade name Wessalith P (Degussa) with a content of about 20% by weight of bound water in an amount of 8-15% by weight is preferably used.
  • Suitable plasticizers are fatty alcohols, fatty acid partial glycerides or wax esters each having 12 to 22 carbon atoms in the fatty residues. Reference is also made to the comments on the fatty substances (D).
  • hydrotropes such as, for example, ethanol, isopropyl alcohol, or polyols may also be used.
  • Polyols contemplated herein preferably have from 2 to 15 carbon atoms and at least two hydroxyl groups.
  • many of the compounds already described among the polyhydroxy compounds can also be used as hydrotropes. Typical examples are • glycerin;
  • Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol, and polyethylene glycols having an average molecular weight of 100 to 1,000 daltons;
  • MethyolENSen in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides especially those having 1 to 8 carbons in the alkyl radical, such as, for example, methyl and butyl glucoside;
  • Sugar alcohols having 5 to 12 carbon atoms such as sorbitol or mannitol,
  • sugars having 5 to 12 carbon atoms such as glucose or sucrose
  • these preparations may in principle contain all other components known to those skilled in the art for such cosmetic compositions.
  • nonionic polymers for example vinylpyrrolidone / vinyl acrylate copolymers, polyvinylpyrrolidone and vinylpyrrolidone / vinyl acetate copolymers and polysiloxanes,
  • Thickeners such as agar-agar, guar gum, alginates, xanthan gum, gum arabicum, karaya gum, locust bean gum, linseed gums, dextrans, cellulose derivatives, e.g. Methylcellulose, hydroxyalkylcellulose and carboxymethylcellu- loose, starch fractions and derivatives such as amylose, amylopectin and dextrins, clays such. As bentonite or fully synthetic hydrocolloids such.
  • hair conditioning compounds such as phospholipids, for example, soybean lecithin, egg lecithin and cephalins, and silicone oils, perfume oils, dimethyl isosorbide and cyclodextrins,
  • Solvents and mediators such as ethanol, isopropanol, ethylene glycol, propylene glycol, glycerol and diethylene glycol, symmetrical and unsymmetrical, linear and branched dialkyl ethers having a total of from 12 to 36 carbon atoms, in particular 12 to 24 carbon atoms, such as di-n octyl ether, di-n-decyl ether, di-n-nonyl ether, di-n-undecyl ether and di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether , n-undecyl-n-dodecyl ether and n-hexyl n-undecyl ether, and di-tert-butyl ether, di-isopent
  • Fatty alcohols in particular linear and / or saturated fatty alcohols having 8 to 30 carbon atoms,
  • Monoesters of C8 to C30 - fatty acids with alcohols having 6 to 24 carbon atoms fiber structure-improving agents, in particular mono-, di- and oligosaccharides, such as glucose, galactose, fructose, fructose and lactose, conditioning agents such as paraffin oils, vegetable oils, eg , As sunflower oil, orange oil, almond oil, wheat germ oil and peach kernel oil and phospholipids, such as soybean lecithin, egg lecithin and cephalin, quaternized amines such as methyl-l-alkylamidoethyl-2-alkylimidazolinium methosulfate, defoamers such as silicones, dyes for staining the agent,
  • Antidandruff active ingredients such as Piroctone Olamine, Zinc Omadine and Climbazole, active ingredients such as Allantoin and Bisabolol, cholesterol,
  • Bodying agents such as sugar esters, polyol esters or polyol alkyl ethers, fats and waxes such as spermaceti, beeswax, montan wax and paraffins, fatty acid alkanolamides, Complexing agents such as EDTA, NTA, ⁇ -alaninediacetic acid and phosphonic acids,
  • Opacifiers such as latex, styrene / PVP and styrene / acrylamide copolymers
  • Pearlescing agents such as ethylene glycol mono- and distearate and PEG-3-distearate,
  • the active ingredient complex (A) directly into dyeing or toning agents, which means using the active ingredient complex (A) according to the invention in combination with dyes and / or dye precursors.
  • oxidation dye precursors of the developer (Bl) and coupler type (B2), natural and synthetic substantive dyes (C) and precursors of naturally occurring dyes, such as indole and indoline derivatives, and mixtures of representatives of one or more of these groups can be used .
  • developer-type oxidation dye precursors (B1) are usually primary aromatic amines having a further, in the para or ortho position, free or substituted hydroxy or amino group, diaminopyridine derivatives, heterocyclic hydrazones, 4-aminopyrazole derivatives and 2,4, 5,6-tetraaminopyrimidine and its derivatives used.
  • Suitable developer components are, for example, p-phenylenediamine, p-toluenediamine, p-aminophenol, o-aminophenol, 1- (2'-hydroxyethyl) -2,5-diaminobenzene, N, N-bis (2-hydroxyethyl ) -p-phenylenediamine, 2- (2,5-diamino) phenoxy) ethanol, 4-amino-3-methylphenol, 2,4,5,6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine, 2,4 Dihydroxy-5,6-dinaminopyrimidine, 2-dimethylamino-4,5,6-triaminopyrimidine, 2-hydroxymethylamino-4-aminophenol, bis (4-aminophenyl) amine, 4-amino-3-fluorophenol, 2-Aminomethyl-4-aminophenol, 2-hydroxymethyl
  • 4,5-diamino-l- (2'-hydroxyethyl) pyrazole Particularly advantageous developer components are p-phenylenediamine, p-toluenediamine, p-aminophenol, 1- (2'-hydroxyethyl) -2,5-diaminobenzene, 4-amino-3-methylphenol, 2-aminomethyl-4-aminophenol, 2,4 , 5,6-tetraaminopyrimidine, 2-hydroxy-4,5,6-triaminopyrimidine, 4-hydroxy-2,5,6-triaminopyrimidine.
  • coupler type oxidation dye precursors (B2) m-phenylenediamine derivatives, naphthols, resorcin and resorcinol derivatives, pyrazolones and m-aminophenol derivatives are usually used.
  • coupler components are m-aminophenol and its derivatives such as 5-amino-2-methylphenol, 5- (3-hydroxypropylamino) -2-methylphenol, 3-amino-2-chloro-6-methylphenol, 2-hydroxy-4 - aminophenoxyethanol, 2,6-dimethyl-3-aminophenol, 3-trifluoroacetylamino-2-chloro-6-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5 - (2'-hydroxyethyl) -amino-2-methylphenol, 3- (diethylamino) -phenol, N-cyclopentyl-3-aminophenol, 1, 3-dihydroxy-5- (methylamino) -benzene, 3- (ethylamino) - 4-methylphenol and 2,4-dichloro-3-aminophenol, o-aminophenol and its derivatives, m-diaminobenzene and its derivatives,
  • Pyridine derivatives such as 2,6-dihydroxypyridine, 2-amino-3-hydroxypyridine, 2-amino-5-chloro-3-hydroxypyridine, 3-amino-2-methylamino-6-methoxypyridine, 2,6-dihydroxy-3 , 4-dimethylpyridine, 2,6-dihydroxy-4-methylpyridine, 2,6-diaminopyridine, 2,3-diamino-6-methoxypyridine and 3,5-diamino-2,6-dimethoxypyridine, naphthalene derivatives such as 1-naphthol, 2-methyl-1-naphthol, 2-hydroxymethyl-1-naphthol, 2-hydroxyethyl-1-naphthol, 1,5-dihydroxynaphthalene, 1,6-dihydroxynaphthalene, 1,7-dihydroxynaphthalene, 1,8- Dihydroxynaphthalene, 2,7-dihydroxynaphthalene and 2,3-dihydroxyna
  • coupler components are 1-naphthol, 1,5-, 2,7- and 1,7-dihydroxynaphthalene, 3-aminophenol, 5-amino-2-methylphenol, 2-amino-3-hydroxypyridine, resorcinol, 4-chlororesorcinol, 2-chloro-6-methyl-3-aminophenol, 2-methylresorcinol, 5-methylresorcinol, 2,5-dimethylresorcinol and 2,6-dihydroxy-3,4-dimethylpyridine.
  • Direct dyes are usually nitrophenylenediamines, nitroaminophenols, azo dyes, anthraquinones or indophenols.
  • Particularly suitable substantive dyes are those under the international designations or trade names HC Yellow 2, HC Yellow 4, HC Yellow 5, HC Yellow 6, Basic Yellow 57, Disperse Orange 3, HC Red 3, HC Red BN, Basic Red 76, HC Blue 2, HC Blue 12, Disperse Blue 3, Basic Blue 99, HC Violet 1, Disperse Violet 1, Disperse Violet 4, Disperse Black 9, Basic Brown 16 and Basic Brown 17 known compounds as well as 1,4-bis- ( ⁇ - hydroxyethyl) - amino-2-nitrobenzene, 4-amino-2-nitrodiphenylamine-2'-carboxylic acid, 6-nitro-1,2,3,4- tetrahydroquinoxaline, hydroxyethyl-2-nitro-toluidine, picramic acid, 2-amino-6-chloro-4-nitrophenol, 4-ethylamino
  • Directly acting dyes found in nature include, for example, henna red, henna neutral, chamomile flower, sandalwood, black tea, buckthorn bark, sage, sawnwood, madder root, catechu, sedre and alkana root.
  • oxidation dye precursors or the direct dyes each represent uniform compounds. Rather, in the hair colorants according to the invention, due to the production process for the individual dyes, in minor amounts, other components may be included, as far as they do not adversely affect the dyeing result or for other reasons, eg. As toxicological, must be excluded.
  • indoles and indolines and their physiologically acceptable salts are used as precursors of naturally-analogous dyes.
  • These groups may carry further substituents, e.g. Example in the form of etherification or esterification of the hydroxy group or alkylation of the amino group.
  • Particularly advantageous properties have 5,6- Dihydroxyindoline, N-methyl-5,6-dihydroxyindoline, N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxyindoline, 5,6-dihydroxyindolin-2-one carboxylic acid, 6-hydroxyindoline, 6-aminoindoline and 4-aminoindoline and 5,6-dihydroxyindole, N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole, 5,6-dihydroxyindole-2-carboxylic acid, 6-hydroxyindole, 6-aminoindole and 4-aminoindole.
  • N-methyl-5,6-dihydroxyindoline N-ethyl-5,6-dihydroxyindoline, N-propyl-5,6-dihydroxyindoline, N-butyl-5,6-dihydroxy-indoline and in particular the 5,6-dihydroxyindoline and N-methyl-5,6-dihydroxyindole, N-ethyl-5,6-dihydroxyindole, N-propyl-5,6-dihydroxyindole, N-butyl-5,6-dihydroxyindole and in particular 5, 6-dihydroxyindole.
  • indoline and indole derivatives in the colorants used in the process according to the invention both as free bases and in the form of their physiologically acceptable salts with inorganic or organic acids, eg.
  • hydrochlorides, sulfates and hydrobromides are used as the hydrochlorides.
  • dye precursors of the indoline or indole type it may be preferable to use them together with at least one amino acid and / or at least one oligopeptide.
  • Preferred amino acids are aminocarboxylic acids, in particular ⁇ -aminocarboxylic acids and ⁇ -aminocarboxylic acids.
  • ⁇ -aminocarboxylic acids in turn, arginine, lysine, ornithine and histidine are particularly preferred.
  • a very particularly preferred amino acid is arginine, especially in free form, but also used as the hydrochloride.
  • Both the oxidation dye precursors and the substantive dyes and the precursors of naturally-analogous dyes are preferably present in the compositions according to the invention in amounts of from 0.01 to 20% by weight, preferably 0.1 to 5% by weight, based in each case on the entire composition, contain.
  • Hair colorants especially when the dyeing is oxidative, whether with atmospheric oxygen or other oxidizing agents such as hydrogen peroxide, are usually adjusted to slightly acidic to alkaline, ie to pH values in the range of about 5 to 11.
  • the colorants contain alkalizing agents, usually alkali metal or alkaline earth metal hydroxides, ammonia or organic amines.
  • Preferred alkalizing agents are monoethanolamine, monoisopropanolamine, 2-amino-2-methyl-propanol, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-ethyl-1,3-propanediol, 2-amino-2 -methylbutanol and triethanolamine and alkali and alkaline earth metal hydroxides.
  • monoethanolamine, triethanolamine and 2-amino-2-methyl-propanol and 2-amino-2-methyl-l, 3-propanediol are preferred within the scope of this group.
  • ⁇ -amino acids such as ⁇ -aminocaproic acid as an alkalizing agent is also possible.
  • oxidizing agents in particular hydrogen peroxide or its addition products of urea, melamine or sodium borate
  • oxidation with atmospheric oxygen as the sole oxidant may be preferred.
  • enzymes which enzymes are used both for the production of oxidizing per-compounds and for enhancing the effect of a small amount of existing oxidizing agents, or enzymes are used, the electrons from suitable developer components (reducing agent) transferred to atmospheric oxygen.
  • Oxidases such as tyrosinase, ascorbate oxidase and laccase but also glucose oxidase, uricase or pyruvate oxidase are preferred. Furthermore, the procedure is called to increase the effect of small amounts (eg, 1% and less, based on the total agent) of hydrogen peroxide by peroxidases.
  • the preparation of the oxidizing agent is then mixed with the preparation with the dye precursors immediately prior to dyeing the hair.
  • the resulting ready-to-use hair dye preparation should preferably have a pH in the range from 6 to 10.
  • Particularly preferred is the application of the hair colorant in a weakly alkaline medium.
  • the application temperatures may range between 15 and 40 ° C., preferably at the temperature of the scalp.
  • After a contact time of about 5 to 45, especially 15 to 30, minutes, the hair dye is removed by rinsing of the hair to be dyed.
  • the washing with a shampoo is eliminated if a strong surfactant-containing carrier, eg. As a dyeing shampoo was used.
  • the preparation with the dye precursors can be applied to the hair without prior mixing with the oxidation component.
  • the oxidation component is then applied, if appropriate after an intermediate rinse.
  • the product is then rinsed and, if desired, shampooed again.
  • the corresponding agent is adjusted to a pH of about 4 to 7.
  • an air oxidation is initially desired, wherein the applied agent preferably has a pH of 7 to 10.
  • the use of acidified peroxydisulfate solutions may be preferred as the oxidizing agent.
  • the formation of the coloration can be supported and increased by adding certain metal ions to the agent.
  • metal ions are, for example, Zn 2+ , Cu 2+ , Fe 2+ , Fe 3+ , Mn 2+ , Mn 4+ , Li + , Mg 2+ , Ca 2+ and Al 3+ .
  • Particularly suitable are Zn 2+ , Cu 2+ and Mn 2+ .
  • the metal ions can in principle be used in the form of any physiologically acceptable salt.
  • Preferred salts are the acetates, sulfates, halides, lactates and tartrates.
  • a fifth object of the invention are cosmetic compositions containing: a. the active substance complex (A) b. and a compound selected from the group of surfactants (E) and / or polymers (G).
  • a sixth aspect of the invention is a method for the treatment of skin or hair in which an agent is applied to the fibers with the active ingredient complex (A) of the invention as claimed in any one of claims 1 to 4, if desired after a contact time of Rinsed again for 1 to 45 minutes.
  • packaging for the cosmetic compositions of the present invention in principle, all known in the art packaging can be used. In particular, these are crucibles, tubes, bottles, sachets. In this case, different embodiments with respect to the shape and the color are possible. However, it is preferred if the packaging has at least a transparent portion of at least 15% of the outer packaging surface. Even better suited to highlight the aesthetic appeal of the pearl powder is a minimum of 30% transparent surface area, but especially 50%, but at least 75% and, most outstandingly, at least 85% transparent surface are outstanding ,
  • the separately prepared compositions (1 and 2) are also each packaged separately in separate containers.
  • Suitable containers are all those known to those skilled and suitable for hair treatment means packaging means such as tubes, bottles or crucibles into consideration.
  • the composition (1) is filled in such a way in one of the mentioned packages, so that it can be removed from it in portions of at least 0.5 to 20 g in a slightly metered manner. This can be done, for example, in the case of a squeeze tube so that marks are attached to the outside of the tube in 0.5 ml increments. These labels then allow the withdrawal of defined volumes of the base composition.
  • an enclosed Spoon with a defined filling volume of about 0.5 ml to 5.0 ml allow the removal of defined amounts.
  • the composition (2) is very particularly preferably packaged in a package, from which the composition can be removed in exactly metered volumes.
  • the accuracy of the volume metering is at least 0.1 ml. Particular preference is given to a metering accuracy of 0.25 ml and most preferably of at least 0.5 ml.
  • a Dosierverpackung is a bottle, tube or crucible with an added Called a pipette.
  • the package may also be accompanied by a pipette for dosing.
  • the lid of the packaging of the base composition is designed so that it is possible to mix the corresponding volumes of the two compositions in this lid.
  • the lid can have a curvature and can accommodate volumes of at least 5 to 50 ml.
  • the mixing and subsequent application of the ready-mixed from the two compositions can be facilitated with a brush or spatula. All necessary packages are then offered in a common outer packaging.
  • the two compositions can be packaged in a corresponding two-chamber package. Such packages are commercially available. The two compositions could then be separated and removed in variable amounts from the respective chambers and mixed together in a separate container.
  • a two-chamber tube can be used.
  • Such tubes are described for example in DE 102004009424.
  • the volume of the products to be removed from the individual containers is variably adjustable.
  • the two are mixed Products either in a separate mixing container or in the hand immediately before use.
  • a two-chamber container which consists of two Dosierspendern.
  • Each dispenser can be separately controlled independently of the other dispenser with respect to the pumping system so that the quantities of product to be dispensed from the respective container are variable. For example, this can be done by two cartridges, in each of which there is an airtight trailing piston. The mixing of the two compositions can ideally take place in the dispenser head.
  • Such packages are offered commercially, for example, by the company DIALPACK GmbH.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des préparations cosmétiques contenant un complexe d'agents actifs (A) à action synergique, composé d'une poudre de perles (notamment de la purine de perle TM), d'au moins un acide carboxylique à chaîne courte, et d'au moins un autre composé choisi parmi i) au moins une vitamine et/ou au moins un précurseur de vitamine et/ou un dérivé de la vitamine et/ou des précurseurs de vitamine (K); ii) au moins un extrait végétal (L) ; iii) au moins une autre protéine et/ou au moins un autre hydrolysat de protéine (P) ; et, iv) au moins un composé de silicone (S). Les préparations cosmétiques selon l'invention sont destinées au traitement de la peau et des cheveux.
PCT/EP2006/008109 2005-09-14 2006-08-17 Perles de culture pulverisees dans des agents cosmetiques WO2007031168A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06776913A EP1924241A1 (fr) 2005-09-14 2006-08-17 Perles de culture pulverisees dans des agents cosmetiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005044002.9 2005-09-14
DE102005044002A DE102005044002A1 (de) 2005-09-14 2005-09-14 Pulverisierte Zuchtperlen in kosmetischen Mitteln

Publications (1)

Publication Number Publication Date
WO2007031168A1 true WO2007031168A1 (fr) 2007-03-22

Family

ID=37199017

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/008109 WO2007031168A1 (fr) 2005-09-14 2006-08-17 Perles de culture pulverisees dans des agents cosmetiques

Country Status (3)

Country Link
EP (1) EP1924241A1 (fr)
DE (1) DE102005044002A1 (fr)
WO (1) WO2007031168A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2444057B1 (fr) 2010-07-09 2018-05-30 Beiersdorf AG Produit de traitement capillaire ayant une teneur en eau liée élevée
CN115919731A (zh) * 2022-12-30 2023-04-07 合曜生物科技(南京)有限公司 化妆品组合物及其制备方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT505787B1 (de) 2007-09-18 2009-06-15 Chemiefaser Lenzing Ag Lyocellfaser

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393045A (en) * 1981-10-29 1983-07-12 Henderson Esther G Cosmetic composition
DE19933902A1 (de) * 1999-06-15 2000-12-21 Jens Poetzsch Kosmetische Formulierungen, enthaltend Perlmutt und Ascorbinsäure oder Ascorbinsäurederivate
CN1313103A (zh) * 2000-03-10 2001-09-19 朱双杰 珍珠粉烧烫伤膏
CN1526326A (zh) * 2003-03-08 2004-09-08 林其溪 水解珍珠的方法及用该方法获取的珍珠果蔬蜂蜜液
US20050226830A1 (en) * 2004-04-07 2005-10-13 Harvard Fang Nano pearl cream
WO2006034750A1 (fr) * 2004-09-24 2006-04-06 Hans Schwarzkopf & Henkel Gmbh & Co. Kg Extrait de perles utilise dans des produits cosmetiques

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393045A (en) * 1981-10-29 1983-07-12 Henderson Esther G Cosmetic composition
DE19933902A1 (de) * 1999-06-15 2000-12-21 Jens Poetzsch Kosmetische Formulierungen, enthaltend Perlmutt und Ascorbinsäure oder Ascorbinsäurederivate
CN1313103A (zh) * 2000-03-10 2001-09-19 朱双杰 珍珠粉烧烫伤膏
CN1526326A (zh) * 2003-03-08 2004-09-08 林其溪 水解珍珠的方法及用该方法获取的珍珠果蔬蜂蜜液
US20050226830A1 (en) * 2004-04-07 2005-10-13 Harvard Fang Nano pearl cream
WO2006034750A1 (fr) * 2004-09-24 2006-04-06 Hans Schwarzkopf & Henkel Gmbh & Co. Kg Extrait de perles utilise dans des produits cosmetiques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200205, Derwent World Patents Index; AN 2002-035100, XP002406954 *
SHIN H S ET AL: "Carbohydrate composition of honey from different floral sources and their influence on growth of selected intestinal bacteria: An in vitro comparison", FOOD RESEARCH INTERNATIONAL, ELSEVIER APPLIED SCIENCE, BARKING, GB, vol. 38, no. 6, July 2005 (2005-07-01), pages 721 - 728, XP004852753, ISSN: 0963-9969 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2444057B1 (fr) 2010-07-09 2018-05-30 Beiersdorf AG Produit de traitement capillaire ayant une teneur en eau liée élevée
CN115919731A (zh) * 2022-12-30 2023-04-07 合曜生物科技(南京)有限公司 化妆品组合物及其制备方法

Also Published As

Publication number Publication date
DE102005044002A1 (de) 2007-03-15
EP1924241A1 (fr) 2008-05-28

Similar Documents

Publication Publication Date Title
DE102006061863A1 (de) Haarkonditionierende Mittel mit ausgewählten kationischen Polymeren und wasserlöslichen Silikonen
DE102005062268A1 (de) Pulverförmige Stylingmittel und deren Spendersysteme
EP1800715A1 (fr) Système cosmétique (kit) de traitement des cheveux et du cuir chevelu
WO2008080701A1 (fr) Compositions cosmétiques contenant des acides gras choisis et du squalène
DE102004062429A1 (de) Wirkstoffgemische zur Restrukturierung keratinischer Fasern
DE102005063096A1 (de) Pflegende Haarbehandlungssmittel mit kammartigen Polymeren I
DE202005021949U1 (de) Haarkonditionierende Mittel mit aminofunktionellen Siliconen
WO2008080708A1 (fr) Composition cosmétique contenant de l'huile d'argan et du beurre de karité
EP2061422A2 (fr) Poudre minérale naturelle dans des produits cosmétiques
WO2007031168A1 (fr) Perles de culture pulverisees dans des agents cosmetiques
WO2007087860A1 (fr) Agents cosmétiques contenant un polysiloxane et une huile ester ainsi que d'autres principes actifs
DE102006059569A1 (de) Konditionierende Zusammensetzung von besonders ausgewählten milden anionischen Tensiden und kationischen oder amphoteren Polymeren in Mitteln zur Behandlung keratinischer Fasern
WO2006029757A1 (fr) Melange de principes actifs pour traiter des fibres keratiniques
WO2007000223A1 (fr) Produits cosmetiques contenant un compose de polyammonium-polysiloxane et d'autres principes actifs
EP2054026A1 (fr) Composition de principes actifs cosmétique contenant de l'extrait de bois de santal
EP2099411A2 (fr) Combinaison synergique de protéines de soie et de métaux sélectionnés
DE102007001008A1 (de) Kosmetische Wirkstoffzusammensetzung mit Ayurveda-Extrakten
EP1791515A1 (fr) Extrait de perles utilise dans des produits cosmetiques
EP1759686A2 (fr) Compositions cosmétiques comprenant de quartz
EP1776077A1 (fr) Produits de nettoyage capillaire volumateurs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006776913

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006776913

Country of ref document: EP